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Sudden unexpected death in the young (SUDY) is the tragic fatality of seemingly 
healthy individuals aged between one and 40 years. Little is known about the 
demographics and risk factors of these cases at Salt River Mortuary (SRM), Cape 
Town. Therefore, this project aimed to retrospectively investigate the burden and 
profile of SUDY cases admitted to SRM, between 1 January 2016 and 31 December 
2018. Of the total 11 588 cases admitted over this period, 833 (7.2 %) were SUDY 
cases, wherein males comprised the majority (64.3 %). Individuals were a median age 
of 31 ± 10.3 years at death, and the main location of death was ‘residential’ (43.5 %). 
There were also significantly more males than females in the age category of 31 - 40 
years who were found outdoors compared to all other locations (p < 0.001). Risk 
factors included physical activity, substance abuse, and co-morbidities with 
concomitant use of chronic medication. More than a third of individuals experienced 
breathlessness prior to death (45.0 %). Of cases with a confirmed natural cause of 
death, the main organ systems involved were pulmonary, cardiovascular, central 
nervous system and gastrointestinal, which parallels international trends. Akin to local 
studies, in analogous amounts, TB and pneumonia were the leading causes of death. 
Additionally, 21.1 % of cases were identified as candidates for genetic testing which 
may resolve undetermined cases or elucidate underlying predisposing factors to 
sudden death. Fortunately, 81.8 % had biological samples available for these 
retrospective analyses. Cases often had missing documentation which advocates for 
training to ensure compliance to standardised procedures. This study shows that 
males aged 31 ± 10.3 years with pulmonary and cardiac-related co-morbidities are the 
most vulnerable for SUDY whilst sleeping. Awareness interventions targeted at this 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
1.1. Introduction 
1.1.1. Background 
Sudden unexpected death in the young (SUDY) is the unforeseen and distressing 
demise of ostensibly healthy individuals between the ages of one and 40 years (Dewar 
et al., 2012). In 2016, there were 5.6 million deaths of individuals worldwide under the 
age of 5 years, with almost 15 000 deaths per day (World Health Organization, 2019a). 
Despite the decline to 5.3 million deaths in 2018 (World Health Organization, 2019b), 
these numbers are alarming, considering the global average life expectancy of the 
human population is 72 years of age (World Health Organization, 2019a). In 2019, a 
large proportion of deaths pertaining to low-income countries, such as the African 
region, were attributed to communicable disease, maternal, perinatal and nutritional 
deficiencies (World Health Organization, 2019c). The proportion of SUDY relating to 
these statistics, however, remains unknown due to minimal research pertaining to 
these deaths.  
Numerous definitions have been provided for sudden unexpected death (SUD) 
wherein it is regarded as the demise of an individual occurring either instantaneously 
or between one and 24 hours since the onset of symptoms (Bowker et al., 2003; Byard, 
2010; World Health Organization, 2010). However, a definition which seems to be 
widely accepted, especially in the medico-legal field, has been provided by Mason 
(1995) whereby he defines SUD as “unexpected death following so rapidly from the 
onset of symptoms that the cause of death could not be certified with confidence by 
the medical practitioner familiar with the patient”. 
To date, forensic studies pertaining to SUD in infants (SUDI), children (SUDC) and 
adults (SUDA) respectively have been performed across South Africa (Tiemensma, 
2010; Tiemensma & Burger, 2012; Mathews et al., 2016; van Deventer, Rossouw & 
du Toit-Prinsloo, 2016; Bennett, Martin & Heathfield, 2019). In the Western Cape and 
Salt River Mortuary (SRM) specifically, however, minimal research has been 
conducted on the SUDY group. Relevant information such as the number of SUDY 
cases, their demographic profile, extent of post-mortem examination conducted, 
cause of death, and social and clinical history pertaining to this group has not been 
well-documented. Obtaining this information on SUDY will aid in identifying risk 
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factors, thereby promoting targeted interventions and translatable research. 
Determining these factors may also aid in reducing the mortality rate by identifying 
living relatives who may be at risk of a similar death. 
Although the United Nations millennium goals were somewhat met in terms of 
reducing child mortality and improving maternal health (Mathews et al., 2016), these 
statistics can be further improved through understanding and addressing underlying 
causes and risk factors. For example, the implementation of a ‘molecular autopsy’ 
could ultimately aid in providing cause of death in undetermined SUDY cases, 
whereby findings can be communicated with, and screened for in the deceased’s 
families. This will ultimately provide closure and promote good maternal and child 
health, which is in line with Sustainable Development Goal (SDG) number three 
(publicly accessible: https://apps.who.int/iris/bitstream/handle/10665/311696/WHO-
DAD-2019.1-eng.pdf; date accessed: 2019, November 4). 
In light of the paucity of information on SUDY in South Africa, this literature review 
therefore aimed to document the relevant legislation and guidelines, establish the 
common causes of death and risk factors for SUDY in other ancestral groups. It also 
aimed to highlight the significance of molecular autopsies as a possible approach to 
addressing the third SDG. 
 
1.1.2. Search strategy 
Three databases, namely Scopus, Web of Science and PubMed, were searched for 
the years 2000-2020 using the keywords “sudden unexpected death in the young”, 
“risk factors”, “undetermined“, and “cause of death”, in three varying combinations 
(Table 1.1). This resulted in nine searches with a total of 959 resultant publications.  
 
Table 1.1: The three search combinations used in the search strategy 
Search 1 sudden unexpected death in young AND risk factors AND undetermined AND cause of death 
Search 2 sudden unexpected death in young AND risk factors AND cause of death 
Search 3 sudden unexpected death in young AND risk factors 
 
Page | 3 of 125 
 
Subsequent to (i) viewing the titles and abstracts, (ii) the exclusion of duplicates across 
the databases, and (iii) the application of the inclusion and exclusion criteria as 
depicted below (Table 1.2), a total of 64 peer-reviewed original articles resulted. 
Thirteen additional original peer-reviewed documents, including abstracts, were 
identified from Primo. Therefore, based on overall relevance, a total of 77 documents 
were selected for this review. The South African Child Death Review pilot (Mathews 
et al., 2016), National Health Act (Act 61 of 2003), Inquest Act (No. 58 of 1959) and 
Centers for Disease Control and Prevention (CDC) guidelines (publicly accessible: 
https://www.cdc.gov/sids/pdf/508suidiguidelinessingles_tag508.pdf; date accessed: 
2020, March 10) were also read in conjunction to the literature.  
 
Table 1.2: Search strategy inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
• Ages: > 1 years and ≤ 40 years 
• Sudden unexpected death in epilepsy 
• Sudden cardiac death 
• Cause of death and/or risk factors 
• Undetermined causes 
• Non-human 
• Not available in English 
• Reviews, case reports and editorials 
• Infant only studies (≤ 1 year old) and > 40 
years old only studies 
• Irrelevance (i.e. gene studies, purely clinical 
based, bereavement counselling) 
 
1.2. Legislation and guidelines surrounding SUD 
1.2.1. South African legislation 
In accordance with the Regulations regarding the rendering of Forensic Pathology 
Services (FPS) (No. R. 359 of 2018) of the National Health Act (Act 61 of 2003) of 
South Africa, fatalities attributable to unnatural causes, such as those that are “sudden 
and unexpected, or unexplained, or where the cause of death is not apparent”, are 
required to undergo medical-legal investigation in terms of the Inquest Act (No. 58 of 
1959) (National Health Act, No. 61 of 2003, 2003:s1; du Toit-Prinsloo et al., 2013). 
The Inquest Act (Act 58 of 1959) mandates that a post-mortem investigation is to be 
performed to aid in ascertaining cause of death in all cases suspected to be of 
unnatural cause (Inquest Act, No. 58 of 1959, 1959:s2). In conjunction with the 
definition for SUD provided by Mason (1995), it can be noted that it is a fundamental 
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task of a forensic pathologist to distinguish between natural and unnatural deaths 
through the performance of post-mortem investigations (Tiemensma & Burger, 2012).  
The Regulations (No. R. 359 of 2018) have provided a basis for the investigation of all 
unnatural deaths in South Africa which is inclusive of (i) obtaining information relevant 
to the death scene from witnesses and family members, (ii) collecting any exhibits or 
specimens from the scene, (iii) obtaining medical records and information pertaining 
to clinical and social history of the deceased, as well as (iv) performing an autopsy 
which may involve both an internal and external examination of the deceased (National 
Health Act, No. 61 of 2003, 2003:s1). It is essential that these autopsies are conducted 
thoroughly to aid in determining the cause of death and to provide closure for grieving 
relatives of the deceased.  
During the medico-legal or post-mortem investigation, biological samples may be 
retained for ancillary investigations which may ultimately aid in establishing cause of 
death. For example, blood and/or tissue may be retained for toxicology or histology 
testing, respectively. However, this is done at the discretion of the forensic pathologist 
performing the investigation, and the type of samples taken is not mandated by 
legislation. Shortcomings arise in SUDY cases deemed as ‘natural’ as no further 
investigations are warranted by law to identify the exact cause of death - resulting in 
these cases having unspecific ‘natural causes’. In many resource-constrained 
mortuaries, including in South Africa, investigations for determining the cause of 
natural deaths is often based purely on clinical and social history, an external 
examination  and an Xmplar-dr chest X-ray (Lodox Systems, Johannesburg) (Mathews 
et al., 2016), thus overlooking sample retention for further analysis. This is an area of 
concern, especially in the epidemiology and public health sectors, as transmissible 
conditions may exist, but may go undetected. 
 
1.2.2. International guidelines for death scene investigation 
Death scene investigation (DSI) guidelines have been established internationally by 
both the United States (US) Department of Justice and US Department of Health and 
Human Services (Centers for Disease Control and Prevention, 1996; U.S. Department 
of Justice, 1999). Not only do these guidelines aid in establishing cause of death, 
thereby differentiating between unnatural and natural deaths and ensuring that justice 
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and closure is received, but they also provide a basis for the DSI which can be 
implemented in other countries.  
Prior to the nineties, there was an absence of standardised procedures pertaining to 
the collection and assessment of information on SUDI cases, wherein procedures 
varied amongst the different states (Centers for Disease Control and Prevention, 
2016). Considering the burden of SUDI cases in the US (Centers for Disease Control 
and Prevention, 2018), a national standardised protocol was established for the DSI 
of these tragic cases. Pivotal information was incorporated within this protocol to aid 
in identifying risk factors and establishing the cause of death, as well as acquiring 
information regarding the manner and circumstances surrounding death (Centers for 
Disease Control and Prevention, 1996). 
The CDC thereafter implemented a Case Registry in 2009 to enhance understanding 
and establish the burden of SUDI cases within the population (Centers for Disease 
Control and Prevention, 2018). Due to a paucity in epidemiological studies on SUDC 
(Chugh et al., 2008), this was expanded into a Sudden Death in the Young Case 
Registry (SDY-CR) in 2013. The SDY-CR was implemented in seven states in 2016, 
incorporating SUD up until the age of 20 years, including both children and 
adolescents (Centers for Disease Control and Prevention, 2018). Furthermore, the 
SDY-CR actively sought after two common causes of death amongst this age group, 
namely sudden cardiac death (SCD) and SUD in epilepsy (SUDEP) (Centers for 
Disease Control and Prevention, 2016). Although various DSI protocols has been 
established internationally, they have not been adopted globally (Bennett, Martin & 
Heathfield, 2019) and thus there is a paucity of DSI information relevant to SUD in 
general. 
 
1.2.3. The Child Death Review 
An additional global guideline of considerable value in understanding SUDY is the 
Child Death Review (CDR) wherein deaths of individuals under 18 years of age 
referred for medico-legal investigation are reviewed (Mathews et al., 2016). CDR 
teams have been established globally in many high-income regions, such as the US, 
wherein data surrounding the circumstances of death pertaining to child deaths are 
reviewed by a multidisciplinary team (Shanley, Risch & Bonner, 2010). This was 
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established to minimise child mortality by highlighting preventable deaths through the 
capturing of this data and the subsequent implementation of targeted interventions 
and public awareness.  
Prior to 2014, South Africa did not have a CDR team, hence this concept was piloted 
at SRM in the Western Cape and Phoenix Mortuary in KwaZulu-Natal (Mathews et al., 
2016). This pilot study was successful in providing a platform to further explore cause 
of death in natural cases, which would otherwise be disregarded due to the legislation. 
Furthermore, it aided in rapidly identifying cause of death and risk factors in these 
cases, expedited police and legal proceedings and linked social workers to at-risk 
households (Mathews et al., 2016). Consequently, the CDR has been implemented 
across the Western Cape, and is considered the gold standard for child death 
investigations. 
 
1.3. Cause of death and risk factors in SUDY 
1.3.1. Overview 
A plethora of articles have documented cause of death and risk factors, such as the 
circumstances surrounding death and demographic data, whereby associations 
between these variables and conditions were established. SUD is generally 
categorised into the various organ systems (Dempers & Van Vuuren, 2006), and in 
the majority of studies, the following systems have been involved: circulatory, central 
nervous, respiratory and gastrointestinal (GIT).  
Based on the literature reviewed, within the SUDY age group (1-40 years old), a 
recurrent cause of death has been identified as either cardiac or epileptic in nature 
and thus termed SCD and SUDEP respectively (van Deventer, Rossouw & du Toit-
Prinsloo, 2016; Haas, 2018). To support this, a summary of the literature identifying 
the main causes of death in various populations and age groups can be seen below 
(Table 1.3). Although the ages characterised in these articles extend beyond that 
mentioned in the inclusion criteria of this review, they do encompass the SUDY group 
of 1-40 years and have thus been incorporated. 
SUD due to infections with risk factors such as co-sleeping and smoking has shown 
greater association with younger individuals and infant deaths (Mathews et al., 2016). 
A study by Amital et al. (2004) had additionally attributed SUDY to meningitis and 
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respiratory conditions, such as asthma, pneumothorax, pneumonia, or pulmonary 
embolism. Hence, it is evident that different causes of death and risk factors tend to 
be associated with different ages at death. 
 





























Denmark 1 month – 18 years 1 974 (Grønborg & Uldall, 2014) 
Sweden 16-74 years 255 (Sveinsson et al., 2020) 
Iceland 11-63 years 3 514 (Einarsdottir, Sveinsson & 
Olafsson, 2019) 
San Diego 18-45 years 3 732 (Karlovich et al., 2020) 
UK ≥ 20 years 83 (Kiani et al., 2014) 
Sweden ≥ 11 years 660 (Sveinsson et al., 2017) 
Finland 1 month – 16 years 245 (Sillanpää & Shinnar, 2013) 
North America 1-70 years 530 (Verducci et al., 2019) 
Netherlands 4-69 years 179 (Vlooswijk et al., 2007) 
West China 5-75 years 3 569 (Mu et al., 2011) 
Kenya 0-50 + years 232 164 (Ngugi et al., 2014) 
Cornwall, UK 2-82 years 93 (Shankar et al., 2014) 
Korea 6-69 years old 35 638 (Ryu et al., 2015) 
Toronto, Canada 19-65 years 24 (Pollanen & Kodikara, 2012) 
Victoria, Australia 11 month-70 years 357 (Opeskin et al., 2000) 
Victoria, Australia 4-71 years 166 (Opeskin & Berkovic, 2003) 
Norway* 20-40 years 26  (Aurlien et al., 2012) 
New Zealand 1.5-67 years 190 (Brennan, Scott & Bergin, 2020) 
Istanbul, Turkey 1-60 years 112 (Melez et al., 2017) 
China 2-80 years 1562 (Ge et al., 2017) 
Denmark 1-35 years 33 022 (Holst et al., 2013) 
Turkey 24-56 years 9 (Gungor et al., 2016) 
Stroke 
 
Japan ≥ 20 years 1 934 (Nagata et al., 2013) 







UK 16-43 years 80 (Krexi & Sheppard, 2017) 
Brazil 10-80 years 899 (Braggion-Santos et al., 2014) 
UK < 35 years 1 033 (Finocchiaro et al., 2018) 
Israel 18-39 years 151 (Amital et al., 2004) 
Toronto 2-45 years 2 937 (Allan et al., 2019) 
Germany 19-40 years 10 (Hellenthal et al., 2017) 
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Tuscany & Genoa 
7-78 years 744 (Maron et al., 2000) 
Spain 14-50 years 52 (Campuzano et al., 2017) 
North Carolina 18-64 years 190 (Lewis et al., 2016) 
Denmark 1-49 years 1 066 (Risgaard, 2016) 
Denmark  1-35 years 625 (Winkel et al., 2011) 
Bosnia & 
Herzegovina 
15-80 years 421 (Omerkić et al., 2009) 
Northwest China < 75 years 1 244 (Zhang et al., 2019) 
Ontarro, Canada 28 days - 18.8 years 80 (Sanatani et al., 2006) 
India 18-35 years 64 (Chaturvedi et al., 2011) 
Italy* 12-35 years 300 (Corrado et al., 2003) 
SCD/ 
Pneumonia 
Cape Town, South 
Africa 
≥ 18 years 816 (Tiemensma & Burger, 2012) 
Pneumonia Pretoria, South 
Africa 




Spain 1-35 years 243 (Romero, Gálvez & Gonzalez, 
2017) 
Asthma Denmark 1-35 years 49 (Gullach et al., 2015) 
*Note: studies marked with an asterisk denote a sub-group of the country’s population was included in the study 
 
Out of the studies reviewed, almost half (49 %) had epilepsy-related causes of death, 
followed by cardiac-related (33 %), with the remaining causes of death comprising less 
than 5.0 % each.  
 
1.3.2. SUDY in the South African population 
Pneumonia, ischaemic heart disease, tuberculosis (TB) and thrombo-embolism 
seemed to be the common causes of death in the South African studies (Tiemensma 
& Burger, 2012; van Deventer, Rossouw & du Toit-Prinsloo, 2016), however, this was 
based on only two studies. Risk factors were identified for each of these causes and 
are presented below. Some associations made by Tiemensma & Burger (2012) were 
that pneumonia and ischaemic heart disease were the common causes of natural 
death in both females and males, whereas pulmonary TB was more associated with 
males and thrombo-embolism with females. In cases where cause of death was 
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ascertained following routine investigation, pneumonia was prominent in the age group 
of 1-5 years in the Pretoria, Gauteng study (van Deventer, Rossouw & du Toit-
Prinsloo, 2016). This is in contrast to infectious diseases being associated with the 
age group of 18-29 years in the Eastern Metropole of the City of Cape Town, Western 
Cape SUDA study (Tiemensma & Burger, 2012). 
Some of the risk factors associated with the SUDA cases (aged eighteen years and 
above) in the Western Cape were acute alcohol poisoning and substance use such as 
“antidepressants, anticholinergic medication, anticonvulsant medication, morphine 
and MDMA” (Tiemensma & Burger, 2012). Moreover, prior medical history 
demonstrated that hypertension and TB were reported in numerous cases. Whilst 
these studies have highlighted causes of death in the South African population, many 
still remain ‘undetermined’ or ‘unspecified’ thus signifying the value of post-mortem 
genetic testing in detecting underlying conditions which could be of cardiac origin (van 
Deventer, Rossouw & du Toit-Prinsloo, 2016). To date, these are the only studies 
encompassing the SUDY age group in South Africa. There is thus a need to collate 
data on SUDY cases, which encompass a wide array of ages, from other mortuaries 
in the Western Cape. SRM is one of the two busiest mortuaries in the Western Cape, 
serving the Western Metropole of the City of Cape Town. It is an academic mortuary 
that currently investigates approximately 4 000 deaths per year and should thus be 
evaluated for SUD. 
 
1.3.3. Common causes of death and risk factors in international populations 
1.3.3.1. Sudden cardiac death 
Although Winkel et al. (2011) stated that SCD in children and adults had not been as 
thoroughly investigated as compared to infant studies, it is an area of research that 
has begun to gain substantial attention due to increasing prevalence of undetermined 
SUD cases. Studies on SCD generally encompass the ages of one to 35 years (Burns 
et al., 2017). However, some studies have identified SCD to affect individuals up to 80 
years of age wherein majority of deaths occur above 40 years of age (Braggion-Santos 
et al., 2014). Nevertheless, these studies do provide insight into SCD predisposition.  
According to Maron et al. (2014), cardiac conditions such as inherited 
cardiomyopathies, channelopathies and ischaemic heart disease are a well-known 
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cause of death in the young. However, this may differ in the South African population, 
but this is currently unknown. Recently, molecular studies have been performed, 
highlighting that fatal cardiac conditions are often due to inheritable genetic variants 
(Farwell & Gollob, 2007; Campuzano et al., 2017; Hellenthal et al., 2017). Studies 
have identified several risk factors for SCD which can be beneficial for at-risk relatives. 
To this end, future investigations should aim to identify high-risk individuals and 
promote genetic and/or clinical screening, with the intention of providing a medically 
actionable or preventative intervention to ultimately reduce the number of SUD cases 
(Burns et al., 2017).  
These risk factors, to varying extents, include physical endurance, hypertension, 
smoking, diabetes, and obesity (Amital et al., 2004; Braggion-Santos et al., 2014; 
Finocchiaro et al., 2018; Allan et al., 2019). Obesity, however, is not always a 
contributory factor to SCD. In the study by Finocchiaro et al. (2018) on individuals with 
SCD under 35 years of age, only 20 % of their study population was considered obese 
(BMI ≥ 30). Nevertheless, it is a risk factor to be considered in understanding this 
condition. Furthermore, medicinal and illicit substance use (Braggion-Santos et al., 
2014; Allan et al., 2019), familial history, asthma and hypercholesterolemia (Amital et 
al., 2004) have also been implicated. In terms of demographics, men are often more 
affected than women (Skinner et al., 2011; Braggion-Santos et al., 2014; Allan et al., 
2019), however, this may fluctuate depending on the study population analysed. 
Winkel et al. (2011) mentions that literature pertaining to population sub-groups is 
more prevalent than nationwide studies due to public awareness campaigns and 
media coverage of these deaths. Nevertheless, these studies do provide insight into 
locally relevant or population-specific risk factors and should thus not be overlooked. 
For example, a study by Amital et al. (2004) conducted on military personnel further 
supports that cardiac diseases are a well-known cause of SUD. In this study, 
ischaemic heart disease was predominantly in the age group of 30-39 years 
accounting for 84 % of deaths, as compared with 9.7 % in the age group of 18-29 
years.  
In terms of the young athlete sub-group, literature has also demonstrated that 
individuals with a family history of cardiac disease are also prone to SCD due to 
physical exertion which exacerbates fatal cardiac arrythmias (Corrado et al., 2003). 
Unlike the risk factors mentioned above, these deaths were inclusive of hyperthermia 
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with subsequent central nervous system (CNS) dysfunction due to heat stroke, CNS 
trauma, uncontrolled asthma and vessel rupture due to injury especially in the neck 
(Maron et al., 1980).  
Although the studies mentioned above exclusively pertain to SCD, other studies have 
demonstrated that cardiac conditions are often interlinked with SUDEP thus 
concomitantly leading to sudden death (Burns et al., 2017; Melez et al., 2017). 
Therefore, understanding SUDEP as a cause of death is also imperative.  
 
1.3.3.2. Sudden unexpected death in epilepsy 
Although SUDEP can be observed in all age groups, it is considered to be most 
prevalent in individuals aged 20-40 years (Holst et al., 2013; Shankar et al., 2013), 
thus comprising the upper end of the SUDY age group. Findings concerning SUDEP 
risk factors have been diverse, hence further research and analysis is required to 
exhibit potential SUDEP risk factors in a clear and concise manner.  
While many studies have concluded well-defined risk factors for SUDEP as grand mal 
seizures, use and lack of use of antiepileptic drugs (AEDs) and polytherapy (Burns et 
al., 2017; Melez et al., 2017; Brennan, Scott & Bergin, 2020), many have noted mental 
disabilities (Hesdorffer et al., 2011; Holst et al., 2013) and the administration of 
anxiolytic drugs (Harden et al., 2017) to be associated with these deaths. Examples 
of AEDs that had been administered included sodium valproate and carbamazepine 
(Aurlien et al., 2012; Brennan, Scott & Bergin, 2020), which may have also been used 
to treat mood disorders. In a case-control study by Aurlien et al. (2012), the use of 
lamotrigine for both mental disability and seizure control had been highly associated 
with SUD in females. Other substances such as recreational drugs, alcohol, 
antidepressants and antipsychotic drugs had also been noted (Brennan, Scott & 
Bergin, 2020).   
Hesdorffer et al. (2011) declared that male sex and early-onset epilepsy are also 
potential risk factors for SUDEP, which is supported by numerous studies (Holst et al., 
2013; Ge et al., 2017; Melez et al., 2017; Brennan, Scott & Bergin, 2020). The 
circumstances surrounding these deaths have also been documented in numerous 
studies (Melez et al., 2017; Brennan, Scott & Bergin, 2020), however, individuals found 
alone are noteworthy as these individuals may have suffered a seizure which could 
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have been controlled had a witness been present. Although the position in which the 
deceased is found is often documented as being prone, this may not necessarily be a 
risk factor for SUDEP but rather a consequence thereof. Overall, it is evident that these 
risk factors demonstrate some overlap with those of SCD thereby substantiating that 
a more comprehensive investigation into these deaths is required. 
 
1.3.3.3. Respiratory-related deaths 
Mathews et al. (2016) conducted a study at SRM, wherein the child (1-14 years) 
mortality rate was established as 34 per 100 000 live births with 60.6 % of deaths 
attributed to natural causes and 4 % remaining undetermined. In addition, this study 
highlighted that deaths of children over the ages of 14 years tended to occur in public 
spaces as compared to younger children who died at home where the principal cause 
of death was pulmonary-related infections (Mathews et al., 2016). However, this is one 
of the few studies which assessed pulmonary-related deaths in the young and thus 
the need for further investigation is highlighted.  
In a study by Chaturvedi et al. (2011), whereby SUD accounted for less than 1 % of 
the population analysed, all cases of respiratory-related disease were female where 
causes of death were due to infection. Analogous to the study by Tiemensma & Burger 
(2012), these infections included pneumonia and TB. Although marginal, asthma and 
pulmonary embolism have also been observed as a cause of SUD (de la 
Grandmaison, 2004; Manu, Kane & Correll, 2011; Berg et al., 2013; Braggion-Santos 
et al., 2014).  
A study was performed in Denmark on SUDY cases where individuals previously had 
uncontrolled asthma (Gullach et al., 2015). Asthma is a common chronic condition 
amongst young individuals in Western regions and the presence of other health 
conditions and diseases, such as long-QT syndrome, may propagate sudden death. 
At autopsy, there may be histological signs of conduction system abnormalities 
(Gullach et al., 2015). However, asthma may only be identified as a contributory factor, 
should there be a previous medical history of the condition, as signs of this condition 
are not exclusively present. Medical history may note that asthmatic individuals had 
symptoms such as chest pain, palpitations, fatigue and seizures prior to death, had 
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there been a witness in their presence (Gullach et al., 2015). Nevertheless, asthma as 
a cause of SUDY is a perplexing matter.  
A pulmonary embolism, conversely, is a pathological condition common to individuals 
aged 1-35 years (Romero, Gálvez & Gonzalez, 2017). It is a blood clot that often 
originates in the deep veins of the leg and subsequently travels to the lung, whereby 
it results in vasoconstriction, ultimately leading to death. More than 90 % of cases go 
undiagnosed and thereby do not receive the necessary treatment to prevent fatalities 
(Konstantinides et al., 2014). Konstantinides et al. (2014) found that older individuals 
are more prone to the condition as compared to young. Risk factors such as prolonged 
immobilisation, a clinical and family history of the disease, use of oral contraceptives, 
age and pregnancy have all been associated with pulmonary embolisms (Romero, 
Gálvez & Gonzalez, 2017). Risk factors were inclusive of trauma, morbid obesity, 
kidney disease and a clinical history demonstrating inadequate treatment for 
symptoms such as limb pain and arrythmias. The presence of recent ingestion of 
psychotropic drugs and alcohol was also identified, as well as cocaine metabolites. 
Although the number of SUDY cases due to a pulmonary embolism are few globally, 
it should be considered in cases of SUD, especially in patients with a history of surgery 
and trauma (Dempers & Van Vuuren, 2006).  
Despite there being common risk factors amongst the literature reviewed, it is evident 
that some of these variables merely suggest potential inheritable conditions and do 
not stand as a confirmation of the inherited disease; unless supported by post-mortem 
genetic testing i.e. molecular autopsies. 
 
1.3.4. Molecular autopsies 
Upon routine investigation, the cause of death is often conclusive. However, in some 
cases, the cause of death may be inconclusive, unspecified (even if deemed as 
natural) or undetermined (Sanchez et al., 2016). These cases therefore warrant further 
research and novel investigative techniques such as a molecular autopsy (Dewar et 
al., 2015), a method using (often retrospectively collected) biological samples to 
establish genetic abnormities resulting in these deaths. A molecular autopsy thus 
potentially aids in defining cause of death. This is supported by a study by Skinner et 
al. (2011) wherein cases between the ages 1-40 years that remained undetermined 
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following post-mortem investigation underwent genetic analysis and long QT 
syndrome was identified as the cause of death in 15 % of cases. 
The neurological, cardiac, and pulmonary conditions mentioned above could 
potentially compromise the health of surviving relatives as several of these are 
inheritable. Therefore, the collection of biological samples is pivotal so that the 
necessary investigative techniques can be applied which may assist in reducing the 
SUD rates. Therapeutic interventions can also be implemented to both manage and 
prevent these potentially diagnosed genetic disorders (Semsarian & Hamilton, 2012). 
However, biological materials are often not retained for molecular autopsies to be 
performed, due to it being discretionary rather than mandatory by law, and thus these 
conditions may go undetected (Dewar et al., 2012). 
Not only has the documentation of these variables allowed for inheritable conditions 
amongst the young to be identified, but it has also emphasised the value of post-
mortem molecular testing. Moreover, it has assisted researchers in identifying which 
genetic variants to screen for. Therefore, these studies have provided insight and 
motivation for similar studies to be performed in a local context.  
 
1.4. Rationale 
Studies pertaining to incidence and risk factors in SUDY have been conducted in many 
developed countries and although this aids in understanding possible risk factors 
concerning individuals in these geographical regions, it does not necessarily highlight 
the risk factors prevalent in the South African population which comprises primarily of 
individuals of African and Admixed ancestries. Nevertheless, these studies have 
underlined the importance of acquiring the relevant information in resolving cause of 
death of these tragic SUDY cases.  
Whilst many of these studies have investigated risk factors in SUDC and SUDA, few 
have investigated SUDY specifically, and more so from a South African perspective. 
As highlighted by Tiemensma & Burger (2012), there is a need to explore SUD so as 
to better understand the risk factors contributing to and surrounding these deaths. It is 
inferred that by obtaining information surrounding the clinical and social history of the 
deceased, it could potentially identify risk factors that increase the risk for (or 
predispose) individuals to SUD.  
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With respect to SRM, there is a deficit of research on individuals classified under 
SUDY and as a consequence of this, an unknown incidence. Establishing the number 
of SUDY admissions pertaining to SRM will allow us to determine the burden that 
these cases place on this mortuary. Additionally, data pertaining to the demographics, 
social and clinical history, cause of death and extent of the post-mortem investigation 
conducted of these cases, have previously not been well-documented in the literature. 
Moreover, it is not evident as to how many of these cases remain ‘undetermined’ 
following post-mortem and could possibly benefit from the developing molecular 
autopsy; and of these, how many have stored biological material to aid in defining the 
cause of death. 
SRM serves the Western Metropole of the City of Cape Town and specifically 
encompasses the catchment areas of ‘Western, Southern, Klipfontein and Mitchells 
Plain districts’ (Clark, Mole & Heyns, 2016). The percentage of these SUDY cases 
wherein cause of death still remains undetermined should be calculated for SRM, to 
allow for comparison with data obtained from other mortuaries within South Africa, 
such as Tygerberg (Tiemensma, 2010) and the Pretoria Medico-legal Laboratory (van 
Deventer, Rossouw & du Toit-Prinsloo, 2016). Furthermore, this data will add to the 
current body of literature. 
The ‘undetermined’ cases that are identified in this project as having biological 
samples available, can be prioritised for future research and/or testing. This may 
include molecular autopsies, to aid in identifying genetic abnormalities, which may 
assist in resolving cause of death. Although this project will not incorporate molecular 
genetic testing, it will seek to identify individuals who may be candidates for additional 
genetic testing, whereby an undiagnosed genetic disease may have predisposed or 
contributed to death. If genetic abnormalities that are potentially contributory to the 
death of an individual are detected, this will eventually allow for these high-risk 
individuals to potentially receive screening for these abnormalities in future research 
(Vaartjes et al., 2009). 
Determining these genetic factors and statistics will not only allow one to gain 
knowledge of SUDY cases at SRM, but also contribute to the public health sector as 
individuals can receive education on the risk factors that could potentially lead to SUD. 
This will allow these individuals to make the necessary lifestyle changes, thereby 
improving their health and mitigating risk for these fatalities; which aligns to the third 
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SDG. Furthermore, should population sub-groups such as young athletes be identified 
as at-risk individuals, awareness campaigns at various athletic facilities could be 
established to promote awareness about SUDY risk factors. 
In conclusion, this literature review has substantiated the need for South Africa to 
adopt similar protocols as those applied internationally in order for the number of 
undetermined SUDY cases to be reduced. Fundamentally, it has provided insight into 
more comprehensive post-mortem investigation process through the inclusion of 
molecular testing. Although cause of death has been primarily cardiac and 
neurological in nature according to literature, the South African population may not be 
alike. There may be varying risk factors within the SUDY age group (1-40 years) as 
demonstrated in previous publications and thus documenting the ages and sub-
categorising this age group is necessary.  
 
1.5. Aim and objectives 
Therefore, motivated by the literature critically evaluated in this review, the aim of this 
research project was to retrospectively investigate the burden and profile of SUDY 
cases, admitted to SRM, Cape Town, between 1 January 2016 and 31 December 
2018. 
To this end, this research project sought to achieve the following objectives:  
• Determine the number of SUDY admissions to SRM during the stipulated period 
• Document the demographics, post-mortem details, and cause of death 
outcome in these cases 
• Determine the number of cases which remained ‘undetermined’ 
• For cases classified as natural, undetermined or under investigation, document 
the social and clinical history, and which have biological samples available 
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CHAPTER 2: METHODS  
2.1. Study design 
The study was a quantitative, retrospective, and cross-sectional investigation of 
medico-legal records concerning SUDY admitted to SRM for a three-year period from 
1 January 2016 to 31 December 2018. 
 
2.2. Characteristics of study population 
Deaths which were “sudden, unexpected and unexplained” as per the Inquest Act (Act 
58 of 1959) were considered in this study. This study focused on all SUDY admitted 
to SRM from the years 2016-2018 (inclusive) within the age group of 1-40 years. 
 
2.3. Ethics 
Ethical approval for this study was granted by the Human Research Ethics Committee 
of the University of Cape Town (HREC Ref: 171/2020) (Appendix A). 
 
2.4.  Data collection 
Autopsy records for the stipulated time period were obtained from the Office Autopsy 
Database (HREC: R036/2014) with authorisation from the FPS Clinical Head at SRM 
(Appendix B). These records were filtered and reviewed to identify the SUDY cases 
after which medico-legal cases folders of these cases were retrieved from the 
archives.  
The following documentation was consulted during data collection: Identification 
Documents (ID) or birth certificate, ‘Contemporaneous Note (Lab. 27): Salt River 
Forensic Pathology Laboratory’, FPS 006(a) FPS 006(b) questionnaire for SUD of 
adults and young children respectively, ‘South African Police Service sudden and 
unexpected death in adults’  form, ‘Road to Health Card’ and an ‘Affidavit in terms of 
Section 212(4), Act 51 of 1977’ generated by the forensic pathologist on the post-
mortem conducted. The contents affiliated with each of these documents have been 
summarised (Appendix C). 
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The variables that were collected from these documents included demographics, post-
mortem details, circumstances surrounding death, cause of death, as well as the social 
and clinical history relevant to these SUDY cases (For a full list: Appendix D). The data 
were captured on a single workbook using Microsoft Excel® 2016 in a macro-enabled 
file format, wherein certain variables only pertained to certain cases as depicted 
(Appendix D).  
Regarding the post-mortem details, a full body low dosage x-ray (LODOX) Xmplar-DR 
(Lodox Systems, Johannesburg) is performed in all cases at SRM prior to further 
investigations. The ‘external’ post-mortem does not require incisions for biological 
sample retention as ancillary investigations are not usually performed, whereas the 
‘full’ post-mortem comprises of a complete internal organ dissection with possible 
ancillary investigations. Furthermore, the ‘partial’ post-mortem comprises of dissection 
of a targeted organ; mainly the neurological region or chest cavity. Both ‘full’ and 
‘partial’ may include ancillary investigations should the forensic pathologist deem it 
necessary. 
Ancestry, as per the FPS 006(a) or (b) form, was only collected for undetermined 
cases that were positively identified and with biological samples available, as these 
cases would be candidates for a future a molecular autopsy. The variable of ‘ancestry’ 
would guide which mutations to screen for in future studies, given the population 
differences in allele frequencies (Nel, 2017). However, the results pertaining to 
ancestry will not be presented herein. Lastly, where discrepant information was noted 
between South African Police Services (SAPS) and FPS records, the information 
provided to FPS was used. 
Double entry validation was performed on all data captured to minimise discrepancies. 
These cases were captured independently and thereafter compared against the 
original workbook to ensure accuracy and consistency. Prior to statistical analysis, the 
cases were recoded using a unique study number to ensure anonymity. 
 
2.5. Data analysis 
The percentage of SUDY admissions was calculated based on the number of SUDY 
cases admitted to SRM out of the total cases during that period, and the sub-group of 
‘undetermined’ cases was tallied and noted. When analysing age data in a biomedical 
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setting, a standard sub-grouping divides ages into five-year categories, for example, 
0-4 years, 5-9 years, etc. (Statistics Canada, 2017). However, due to scarce 
observations, multiple testing and the exclusion of infants (< 1 years old), age 
categories were formed in ten-year increments (i.e. 1-10 years, 11-20 years, 21-30 
years, 31-40 years). Basis for these age categories was as a result of a previous 
publication in a forensic setting (Faduyile et al., 2017), as well as recent COVID-19 
statistics on infection rates by age across the South African population (Hartle, 2020; 
Spaull, 2020). This sub-grouping subsequently allowed for effective statistical 
procedures to be performed and the retention of meaningful information on which 
individuals were most at-risk. 
In terms of social history, substances of abuse, and participation in physical activity 
were evaluated. However, in the age category of 1-10 years, additional aspects of 
social history were evaluated which included ‘maternal level of education’ and ‘annual 
household income’.  
In terms of clinical history, use of medicinal substances, symptoms that preceded or 
transpired at death, medical history and family history were evaluated. All aspects of 
social and clinical history have been graphically represented ranked from highest to 
lowest for each of the age categories. Furthermore, they have been divided per sex 
for each sub-category. Where clinical history variables contributed less than 6.0 % 
each, these were grouped together as ‘other’, but the detailed breakdown of all data 
can be found in Appendix E. 
Statistical tests performed on the data to address the aims and objectives of this study 
included a test of proportions, Wilcoxon rank-sum (Mann-Whitney) test, Chi-squared 
and Fischer’s Exact. A p-value of 0.05 was considered to be statistically significant 
and where multiple tests were performed, a post-hoc Bonferroni’s correction factor 
was applied. Significant p-values have been denoted by an asterisk in figures and 
tables. To identify whether significant differences exist, variables were compared per 
sex for each age category. 
The software used for analyses and for visualisation was Stata Version 15 and 
Microsoft Excel 2016. The data has been reported herein in a collective format using 
percentages, graphs, and tables to ensure anonymity. However, in many cases 
information was not available for every variable either due to lack of response, missing 
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documentation or it was not specified. This means that each variable has a different 
denominator which represents the number of cases for which this data was available. 
Therefore, the percentages portrayed have been calculated from the available data 
pertaining to that variable. For more information on these amounts of missing data, 
see Appendix E. 
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CHAPTER 3: RESULTS 
3.1. Burden of SUDY at SRM 
A total of 11 588 cases were received at SRM for the three-year period between 1 
January 2016 and 31 December 2018 with an average of 3 863 cases annually. There 
was a considerable increase in the percentage of SUDY cases between 2016 (195/3 
660; 5.3 %) and 2017 (315/3 885; 8.1 %), followed by a minor decline in 2018 (323/4 
043; 8.0 %). Nevertheless, out of the total cases for the three-year period, 833/11 588 
(7.2 %) were SUDY cases and thus included for further analysis (Figure 3.1). All cases 
which were under investigation, undetermined or had non-specific natural causes were 
identified as candidates for future molecular autopsies (176/833; 21.1 %). Fortunately, 
144/176 (81.8 %) of candidate cases had biological samples available for these future 
investigations. Biological samples available for molecular autopsies were tallied, 
wherein 46 cases had blood, 12 cases had formalin fixed paraffin embedded (FFPE) 









Figure 3.1: Onion chart describing the total number of cases admitted to SRM between 01 January 2016 and 31 
December 2018, and the subsets of cases relevant to this study. SUDY cases comprised 7.2 % of the cases 
admitted to SRM. 
SRM: Salt River Mortuary. SUDY: sudden unexpected death in the young. 
 
3.2. Demographics of study population 
Upon admission, the demographic details of the study population were documented. 
Males comprised the majority of cases (536/833; 64.3 %) and the median age of SUDY 
individuals was 31 ± 10.3 years. While perhaps not clinically relevant, the median age 
* 
 
Cases with biological samples available 
(n = 144/176; 81.8 %) 
SUDY cases  
(n = 833/11 588; 7.2 %) 
Cases identified for molecular autopsy 
(n = 176/833; 21.1 %) 
SRM cases 
(N = 11 588) 
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for males (31 ± 10.2 years) was significantly different from that of females (29 ± 10.5 
years) (p = 0.01) (Figure 3.2).  
 
 
Figure 3.2: Age distribution between males and females in SUDY cases. Males comprised the majority of the study 
population (536/833; 64.3 %). The median age of the SUDY population was significantly different between males 
and females, specifically in the 15-16 year old and 30-31 year old age brackets (denoted by an asterisk). 
 
3.3. Profile of SUDY cases 
When considering the profile of these cases, factors such as geographical location, 
day of the week, month of year and circumstances surrounding death were reviewed. 
Identified geographical hotspots, wherein almost a quarter of SUDY cases had 
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Figure 3.3: Heatmap of SUDY cases admitted to SRM. Red denotes the suburbs with hotspots, namely Nyanga 
and Gugulethu. 
 
There was a relatively even distribution of SUDY cases over the week, with an 




Figure 3.4: Days of the week portrayed for SUDY cases wherein cases were fairly even distributed throughout the 
























Days of the week
1-10 years (86/833; 10.3 %) 11-20 years (65/833; 7.8 %)
21-30 years (262/833; 31.5 %) 31-40 years (420/833; 50.4 %)
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Cases aged 1-20 years were fairly evenly distributed over the months. However, in the 
21-30 year age group, there was a spike in June with a slight upward trend until 
December. In the 31-40 year age group, there was an upward trend throughout the 
year except for plummets in May and August. (Figure 3.5). 
 
 
Figure 3.5: Median SUDY cases per month of year for the different age categories. December was the month with 
the most SUDY cases overall.   
 
The circumstances surrounding death were reviewed which showed that in almost half 
of the cases, activity at death had not been specified during the interview with the 
family (372/833; 44.7 %) and in a further 18.4 % (153/833) of cases, it was unknown 
as a result of being unwitnessed. However, when it was specified, death occurred 
during sleep (176/308; 57.1 %), during rest (79/308; 25.6 %) or whilst walking (21/308; 
6.8 %). The remainder of the activities did not have any major contribution (< 3.0 % 
each) (Figure 3.6). Furthermore, when comparing activity at death, no significance 




























1-10 years (n = 86/833; 10.3 %) 11-20 years (n = 65/833; 7.8 %)
21-30 years (n = 262/833; 31.5 %) 31-40 years (n = 420/833; 50.4 %)
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Figure 3.6: Varying activities at death. The leading activities at death were sleeping (176/308; 57.1 %), resting 
(79/308; 25.6 %) and walking (21/308; 6.8 %). 
 
The main position of individuals was lying down (430/452; 95.1 %), most commonly in 
the supine position (Figure 3.7). However, in 45.7 % (381/833) of the cases, the 
position at death was not specified. The minority of cases were reported to be ‘sitting’ 
(14/452; 3.1 %). No significance was identified between males and females per each 
age category when comparing position at death. 
 
 
Figure 3.7: Varying positions of the deceased at death. The main position at death was supine (303/452; 67.0 %) 
followed by prone (66/452; 14.6 %). 
 
The main location of death was residential (362/832; 43.5 %) followed by medical 
centre (292/832; 35.1 %) and outdoors (96/832; 11.5 %) (Figure 3.8). There were also 
significantly more males than females in the age category of 31-40 years who were 
found outdoors at death compared to all other locations (p < 0.001). 
Sleeping (176/308; 57.1 %)
Resting (79/308; 25.6 %)
Walking (21/308; 6.8 %)
Exercising (7/308; 2.3 %)
Bathroom-related (7/308; 2.3 %)
Playing (5/308; 1.6 %)
Religious/cultural (3/308; 1.0 %)
Cooking/cleaning (3/308; 1.0 %)
Driving (2/308; 0.6 %)
Dancing (2/308; 0.6 %)
Climbing (1/308; 0.3 %)
Firefighting (1/308; 0.3 %)
Moving tiles (1/308; 0.3 %)
Supine (303/452; 67.0 %)
Prone (66/452; 14.6 %)
Side (61/452; 13.5 %)
Sitting (14/452; 3.1 %)
Other (8/452; 1.8 %)
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Figure 3.8: Counts and percentages of varying locations at death. Most SUDY cases occurred in residential 
locations (362/832; 43.5 %), medical centres (292/832; 35.1 %) and outdoors (96/832; 11.5 %). 
 
3.4. Post-mortem details 
The post-mortem examination was conducted by the forensic pathologist with the 
purpose of determining cause of death. The mean number of days between the date 
of death declaration and date of post-mortem was 4 ± 4.6 days and ranged between 
0 and 97 days. Alleged cause of death was documented in 581/833 (69.7 %) of SUDY 
cases, whereas the remainder were still being investigated and thus a final post-
mortem report had not yet been issued. Nevertheless, of the cases where a 
preliminary or final post-mortem report was available (704/833; 84.5 %), the majority 
of cases had a full post-mortem examination (385/704; 54.7 %), followed by external 
(266/704; 37.8 %) and partial (53/704; 7.5 %) respectively.  
The main ancillary investigation performed in these SUDY cases was LODOX 
(673/704; 95.6 %), followed by toxicology (205/704; 29.1 %), histology (198/704; 28.1 
%) and microbiology (41/704; 5.8 %). Furthermore, in 2.4 % (17/704) of the cases, 
alternate ancillary investigations, such as genetics, haematology, biochemistry, 
immunology, and neuropathology were performed. In numerous cases, more than one 
ancillary investigation was performed to aid in establishing cause of death, and in four 
cases all categories of ancillary investigations were performed (Figure 3.9). 
Residential (362/832; 43.5 %)
Medical centre (292/832; 35.1 %)
Outdoors (96/832; 11.5 %)
Ambulance (15/832; 1.8 %)
Jail (12/832; 1.4 %)
Undertaker (11/832; 1.3 %)
Transport-related (11/832;  1.3 %)
Other (82/832; 4.0 %)
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Figure 3.9: Venn diagram indicating counts of ancillary investigations performed. LODOX was the main ancillary 
investigation performed both solely (396/704; 56.3 %) and in conjunction with other ancillary investigations i.e. 
toxicology (79/704; 11.2 %).  
LODOX: Low dosage X-ray 
 
3.5. Cause of death outcome 
The majority of SUDY cases were deemed to have demised from natural causes 
(515/833; 61.8 %), while 5.2 % (43/833) had unnatural causes following post-mortem 
examination. The minority of cases had undetermined causes of death (23/833; 2.8 
%), while a further 123/833 (14.8 %) cases were still under investigation. Cases where 
post-mortem reports were unavailable or missing were marked as ‘unknown (missing)’ 
(129/833; 15.5 %) (Figure 3.10).  
With respect to the unnatural cases, there was no need to further investigate these 
cases for risk factors or a genetic predisposition as the alleged cause of death was 
deemed to be from unnatural causes. Moreover, it is unknown whether the cases that 
were ‘unknown (missing)’ were either natural or unnatural and thus these were 
excluded from further analyses pertaining to risk factors to avoid assumptions.  
Nevertheless, the unnatural deaths were mainly due to blunt trauma (13/43; 30.2 %), 
alcohol toxicity (6/43; 14.0 %), the ingestion of a noxious substance (6/43; 14.0 %), or 
the aspiration of gastric contents (6/43; 14.0 %) as depicted (Figure 3.10). 
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Figure 3.10: Alleged manner of death in all SUDY cases with specific cause of death for unnatural cases. Blunt 
trauma was the main unnatural cause of death to transpire (13/43; 30.2 %). 
 
Of the natural cases, 485/515 (94.2 %) had specified natural causes which aligned to 
one or more organ system. The main organ systems involved in SUDY were 
pulmonary (235/485; 48.5 %), cardiovascular system (CVS) (153/485; 31.5 %), CNS 
(54/485; 11.1 %) and GIT (50/485; 10.3 %) (Appendix E). The ‘other’ organ system 
category included the lymphatic, integumentary, reproductive, endocrine, and multi-
system (< 2.0 % each) (Figure 3.11). Moreover, infectious diseases accounted for 64.9 
% (315/485) of specified natural cases overall. 
There was an overlap between the pulmonary and CVS in 29/485 (6.0 %) cases,  and 
there were significantly more males than females in the age category of 31-40 years 




















Unnatural: blunt trauma (1.6 %)
Unnatural: alcohol toxicity (0.7 %)
Unnatural: noxious substance (0.7 %)
Unnatural: aspiration and airway obstruction
(0.7 %)
Unnatural: medical negligence (0.2 %)
Unnatural: sharp trauma (0.2 %)
Unnatural: hyperthermia (0.2 %)
Unnatural: anaphylactic shock (0.1 %)
Unnatural: eroded feeding tube (0.1 %)
Unnatural: ruptured berry aneurysm (0.1 %)
Unnatural: smoke inhalation (0.1 %)
Unnatural: strangulation (0.1 %)
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Figure 3.11: The main organ systems involved in natural deaths, wherein the causes of death in all organ systems 
except cardiovascular were predominately infectious in nature. 
CVS: Cardiovascular; CNS: Central nervous system; GIT: Gastrointestinal 
 
Cause of death was summarised for all specified natural cases, whereby the ‘other’ 
category accounts for causes of death with less than five cases per cause (Figure 
3.12).  
 
Figure 3.12: Summary chart of the specified causes of death involved in natural deaths. Pulmonary and 















































































































































Infectious and non-infectious causes of death per each organ system
Pneumonia (50/485; 10.3 %)
Tuberculosis (45/485; 9.3 %)
Cardiovascular pathology (38/485; 7.8 %)
Respiratory pathology (34/485; 7.0 %)
Lung disease (26/485; 5.4 %)
Cardiorespiratory pathology (21/485; 4.3 %)
Ischaemic heart disease (18/485; 3.7 %)
Myocardial infarction (18/485; 3.7 %)
Pulmonary embolism (16/485; 3.3 %)
Meningitis (16/485; 3.3 %)
Epilepsy (13/485; 2.7 %)
Diarrhoea/dehydration (12/485; 2.5 %)
Pulmonary infection (12/485; 2.5 %)
Coronary artery thrombosis (9/485; 1.9 %)
Perforated gastrointestinal ulcer (7/485; 1.4 %)
Pancreatitis (6/485; 1.2 %)
Hypertensive heart disease (6/485; 1.2 %)
Liver pathology (5/485; 1.0 %)
Cystercicosis (5/485; 1.0 %)
Haemoptysis (5/485; 1.0 %)
Other (123/485; 25.4 %)
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There were more than 50 different causes of death, wherein the leading causes of 
death overall were pneumonia (50/485; 10.3 %) and TB (45/485; 9.3 %). Other 
pulmonary-related causes were non-specific respiratory pathologies (34/485; 7.0 %), 
lung disease (26/485; 5.4 %) and pulmonary embolism (16/485; 3.3 %). 
Non-specific cardiovascular pathologies (21/485; 4.3 %), ischaemic heart disease 
(18/485; 3.7 %) and myocardial infarction (18/485; 3.7 %) were common causes 
pertaining to the CVS. Moreover, meningitis (16/485; 3.3 %) and epilepsy (13/485; 2.7 
%) were the main causes pertaining to the CNS. Lastly, diarrhoea/dehydration 
(12/485; 2.5 %), perforated gastrointestinal ulcers (7/485 %) and liver pathology (5/485 
%) were prominent in the GIT. 
When analysing cause of death according to age categories, the major trend was that 
pneumonia was among the leading two causes of death per each age category 
(Appendix F). However, there were no significant differences between sex per age 
category for the varying causes of death. 
 
3.6. Social and clinical history 
The social and clinical history of the deceased was the final aspect reviewed which 
allowed for the identification of potential risk factors contributing to SUDY. These 
variables were collated for the SUDY cases which were natural, under investigation, 
and undetermined (i.e. those which were not unnatural). 
 
3.6.1. Social history 
Overall, more than half of SUDY cases (330/568; 58.1 %) engaged with one or more 
substance(s) of abuse. These substances were documented under three main 
categories: (i) alcohol (225/568; 39.6 %), whereby 75.1 % was beer (169/225), 26.2 
% was brandy (59/225) and 22.6 % was wine (51/225); (ii) illicit drugs (133/568; 23.4 
%), whereby Methamphetamine (72/133; 54.1 %), Cannabis (70/133; 52.6 %), and 
Mandrax (53/133; 39.8 %) were the main drugs used; (iii) tobacco products (181/568; 
31.9 %), whereby 90.6 % were cigarettes (164/181). Engagement with alcohol and 
smoking occurred in 65/568 (11.4 %) cases and in 42 cases (7.4 %) all three 
substances were used (Figure 3.13).  
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Figure 3.13: Venn diagram showing the number of cases where more than one substance of abuse was used. 
Numerous substances were used concomitantly and in 42 cases all substances were used. Alcohol was the main 
substance used both solely (97/568; 17.1 %) and in conjunction with another substance i.e. smoking (65/568; 11.4 
%). 
 
Although substances of abuse had not been used in the majority of cases in the age 
category of 1-10 year olds, engagement with smoking was noted in a single case 
(Figure 3.14). The specific substance, however, was not stipulated. The main 
substance of abuse used in the remaining three age categories was alcohol wherein 
more males had engaged with alcohol and smoking than females, but this was not of 
statistical significance. In the age category of 31-40 years, however, there were 
significantly more males than females who engaged with illicit drugs compared to all 
other substances of abuse (p = 0.012). 
Of the 661 cases, 12 individuals were documented to have engaged with physical 
activity prior to death with a median age of 31 ± 10.3 years. Seven of these individuals 
(7/12, 58.3 %) were considered to have demised from cardiovascular causes and one 
from asthma (1/12; 8.3 %), while the remainder (4/12, 33.3 %) were still under 
investigation. A significant association was found between death during physical 
activity and individuals who had suffered demise due to a comprised CVS (7/8; 87.5 
%) (p = 0.011), however, the sample size was very small. 
Two additional aspects of social history were documented for the 1-10 year age 
category due to the vulnerability of these individuals. In 34/66 (51.5 %) cases, the 
maternal level of education was documented, wherein majority of these cases, the 
mother had a secondary (grade 8-12) education (31/34; 91.2 %) (Figure 3.14). 
Although household income was not documented in the majority of cases, when 
provided (10/66; 15.2 %), it had ranged from R 0 to R 120 000 per annum.  





Figure 3.14: Social history percentage per sex in (A) 1-10 years (B) 11-20 years (C) 21-30 years and (D) 31-40 years. One female aged 1-10 years had engaged with smoking 
and majority of cases had a secondary maternal level of education. More males than females aged 11-20 years had engaged with each substance of abuse with smoking being 
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3.6.2. Clinical history 
In more than half of the cases, no medicinal substance was used (315/553; 57.0 %). 
Nonetheless, within the pharmaceutical products category, chronic medication 
accounted for 42.3 % (234/553) and traditional medicine accounted for 1.5 % (8/553) 
(Figure 3.15). No significance was identified between the specific medicinal substance 
used and any of the causes of death nor medical history identified.  
 
Figure 3.15: Venn diagram showing number of cases where medicinal substances were used. In more than half 
of the cases (315/553; 57.0 %), no medicinal substance was used. 
 
Additional clinical risk factors have been graphically represented herein for each age 
category per sex. Symptoms that contributed more than 10 % have been depicted 
(Figure 3.16), whereas medical (Figure 3.17) and family history (Figure 3.18) that 
contributed more than 5 % has been portrayed. These risk factors have been ranked 
from highest to lowest for each age category. Medical history included both chronic 
and acute illnesses and/or infections. For further information on the remaining risk 
factors, see Appendix E. 
In all age categories, there were no significant differences between males and females 
for any of the clinical aspects. Vomiting was identified as one of the leading symptoms 
in all age categories accounting for more than a quarter of cases (163/540; 30.2 %). 
In the age category of 1-10 years, fever (21/63; 33.3 %) and diarrhoea (19/63; 30.2 
%) occurred in approximately a third of cases. Furthermore, breathlessness had 
occurred primarily in the three older age categories followed by chest pain in 
individuals 21-40 years old. (Figure 3.16).






     
 
Figure 3.16: Percentage of symptoms that preceded and/or transpired at death per sex in (A) 1-10 years (B) 11-20 years (C) 21-30 years and (D) 31-40 years. Individuals aged 
1-10 years experienced leading symptoms of vomiting, fever and diarrhoea, whereas breathlessness, vomiting and chest pain were among the leading symptoms experienced 
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Majority of cases had no documented medical history in all age categories. 
Nonetheless, a history of TB exposure and HIV exposure was well-identified in 
individuals 1-10 years and 31-40 years compared to other conditions noted in those 
age categories. Furthermore, approximately 13 % of cases had a history of epilepsy 
in the age categories of 11-20 (6/44) and 21-30 (20/175) years. (Figure 3.17) 
 
Figure 3.17: Medical history counts per sex in (A) 1-10 years (B) 11-20 years (C) 21-30 years and (D) 31-40 years. 
In individuals ≤ 10 years and ≥ 31 years, HIV and TB exposure were prominent. Moreover, numerous individuals 
experienced epilepsy in ages 11-30 years.  
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Parallel to medical history, the majority of cases in all age categories did not have a 
family history of ailments. However, in the latter three age groups, asthma, previous 
sudden death, and heart disease were presented. In contrast, individuals aged 1-10 
years showed a family history of HIV and high blood pressure (Figure 3.18). 
 
Figure 3.18: Family history counts per sex in (A) 1-10 years (B) 11-20 years (C) 21-30 years and (D) 31-40 years. 
In all age categories, majority of cases had no known family history. More males than females aged 1-10 had a 
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CHAPTER 4: DISCUSSION AND CONCLUSION 
4.1. Introduction 
This study sought to collate data pertaining to SUDY at one of the busiest mortuaries 
in the Western Cape, with the intention of describing the profile and risk factors of 
individuals who most vulnerable. SUDY has not been studied before at SRM and thus 
this dissertation documents the first empirical data pertaining to this important, yet 
under-studied, population group. 
Although previous studies have been conducted internationally and at other forensic 
facilities within South Africa on SUDC and SUDA, which overlap with the SUDY age 
group (1-40 years), local publications on SUDY as a focus have also not been 
produced. Research conducted by Tiemensma (2010) at Tygerberg Mortuary between 
2001 and 2005 established that there had been no previous studies performed on 
SUDA (>18 years) in South Africa and thus the need was highlighted to further 
investigate these cases to aid in establishing common causes of death within this 
population. It was stated that out of the approximate 2 700 cases received annually, 
250-380 cases were rendered “sudden and unexpected” or “unknown” (Tiemensma, 
2010). Additionally, van Deventer, Rossouw and du Toit-Prinsloo (2016) performed a 
study on SUDC (1-18 years) pertaining to the Pretoria Medico-legal Laboratory 
wherein less than one percent of deaths were considered to be SUD (van Deventer, 
Rossouw & du Toit-Prinsloo, 2016).  
While the proportion of these deaths may be small, this may be overshadowed by the 
large burden of homicide investigations in South Africa (Mole, 2019). The absolute 
number of SUDY cases is nevertheless substantial, which is concerning considering 
the emotional distress that accompanies these cases. Thus, it is crucial to establish 
means to minimise these tragic fatalities and provide closure to grieving relatives. 
Therefore, the collation of data on the burden, profile and risk factors surrounding 
SUDY cases from other mortuaries in South Africa such as SRM is befitting. 
Investigating this wide-ranging age group is imperative as it encompasses both 
vulnerable individuals (children) and key determinants of our South African economy 
(young adults) (Statistics South Africa, 2020). Limitations, however, arise in that the 
findings presented herein cannot be fully compared within the local context due to the 
paucity of comparable literature. Nonetheless, this study has added to the current body 
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of literature by shedding light on SUD from the Western Metropole of the City of Cape 
Town perspective. 
SRM is one of the busiest mortuaries in the country, having received an average of 3 
863 forensic cases annually between the study period of 1 January 2016 and 31 
December 2018. Out of the total forensic cases for the three-year period, SUDY 
accounted for 7.2 %. Of this 7.2 %, approximately 1.0 % were aged 1-18 years 
(Appendix E), which is similar to the aforementioned local SUDC study (van Deventer, 
Rossouw & du Toit-Prinsloo, 2016). Whereas the remaining 6.2 % pertained to 18-40 
years which also parallels the local SUDA study (Tiemensma & Burger, 2012).  
 
4.2. General profile and characteristics of SUDY 
In South Africa, approximately 35.1 % of the total population comprise the youth (15-
34 years) (Statistics South Africa, 2020). Within this study, the median age of 
individuals was 31 ± 10.3 years, with majority of cases occurring above eighteen years 
(Figure 3.2). In the majority of studies, mean age is provided rather than median thus 
comparison is hindered. However, in a SUDY study which focused on stroke as a 
cause of death, the median age was fairly similar - 33 years (Ågesen et al., 2018). 
Males had comprised the majority of cases (64.3 %) overall and there were 
significantly more males in the 15-16 year and 30-31 year age brackets specifically (p 
= 0.01). The trend for more males parallels numerous international studies (Skinner et 
al., 2011; Zhuo et al., 2012; Berg et al., 2013; Allan et al., 2019). 
In the majority of cases, individuals had demised whilst sleeping (57.1 %) which is in 
accordance with the main location of death being residential (43.5 %). This trend for 
residential locations is indeed consistent with literature (Nilsson et al., 1997; Lear-Kaul, 
Coughlin & Dobersen, 2005). However, in contrast to other study settings wherein 
many deceased were found in a prone position (Kloster & Engelskjøn, 1999; Melez et 
al., 2017), individuals had been found positioned supine herein. Though none of these 
circumstances surrounding death demonstrated significant differences between sex in 
any of the age categories, they do depict the unexpectedness of these cases. Thus, 
taking heed of the lifestyle choices and behavioural patterns of these young individuals 
to safeguard their well-being is an unquestionable obligation. With the South African 
youth being primarily responsible for financial security of numerous households and 
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the country as a whole (Brand South Africa, 2015), ensuring that they receive 
adequate education, access to resources and healthcare which will ultimately enhance 
longevity is sagacious. 
 
4.3. The substance abuse crisis in South Africa 
A distinct substance abuse crisis has emerged amongst the youth of our country with 
ramifications of violent behaviour (Auckloo & Davies, 2019), unsafe sexual practices, 
chronic morbidities and tragic fatalities (Ferrell, 2016). Engagement with substances 
of abuse (i.e. alcohol, tobacco products or illicit drugs) was identified as a potential risk 
factor for SUDY in our study which counterparts the local study on SUDA by 
Tiemensma & Burger (2012), as well as international literature (Braggion-Santos et 
al., 2014; Allan et al., 2019). It was determined that individuals had engaged with one 
or more substance of abuse in more than half of SUDY cases (330/568; 58.1 %) with 
alcohol being the primary substance consumed (Figure 3.12). 
The Western Cape has numerous suburbs of low socio-economic status, wherein 
residents often have access to unlicensed taverns (i.e. shebeens) (Ferrell, 2016) and 
limited accessibility to medical services and resources (Taani & Muller, 2012). Within 
this study, the densely populated and low socio-economic status neighbouring 
suburbs of Nyanga and Gugulethu were identified as hotspots for SUDY (Figure 3.3), 
accounting for approximately a quarter of cases (199/833; 23.9 %). Most cases 
(494/833; 59.3 %) had occurred over the weekend period (Friday-Monday) (Figure 
3.4), which is potentially a result of more individuals engaging with substances of 
abuse during this time (Parker & Williams, 2003; Van Wersch & Walker, 2009; 
Kuntsche & Labhart, 2012).  
In the age category of 31-40 years specifically, there were significantly more males 
than females who had engaged with illicit drugs compared to all other substances of 
abuse (p = 0.012). Recent statistical reports on substance abuse in our youth have 
demonstrated that more males had engaged with Cannabis in its various forms 
compared to females, thus corroborating this finding (Statistics South Africa, 2020). 
Interestingly, a single case within the 1-10 year age bracket had documented 
engagement with smoking (Figure 3.13), though the specific substance was not 
documented. This result was unsurprising given that 6.8 % of adolescents engage with 
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tobacco products prior to ten years old according to a South African based survey 
conducted in 2008 (Reddy et al., 2010). The World Health Organisation has 
additionally indicated that learners often use substances as a coping mechanism for 
verbal or physical abuse, amongst others (World Health Organization, 2020). This 
case remains under investigation following a full post-mortem and thus further 
research should be conducted to understand whether physical or verbal abuse did in 
fact play a role in this case. Nonetheless, this finding does highlight that substance 
abuse is present in our communities and should physical and verbal abuse be 
identified, there may be a need for programmes to be implemented to counteract this.  
Given that only 29.1 % of cases herein had toxicology performed (Figure 3.9), the true 
prevalence of substances in these SUDY cases may be under-reported. For instance, 
a prospective study was recently performed within the local setting, where toxicology 
was applied to a cohort of SUDI cases who would ordinarily not have been candidates 
for toxicology testing based on their clinical and social history. The results showed that 
83.0 % of infants had at least one substance detected, and 11 % infants had 
Methamphetamine present in their bodies (Louw, 2020). These results demonstrated 
that the true presence of toxicological substances is likely to be greater than reported, 
and it motivates for routine toxicology to be performed in all cases of SUD. 
Thus, raising awareness through public campaigns on the impact of substance abuse 
on lifestyle and implementing policies to curtail this risky behaviour would be prudent 
measures to reduce fatalities. Educational awareness has not necessarily been 
efficacious (Ferrell, 2016), however, the enhancement of our healthcare systems to 
identify individuals at-risk and the subsequent implementation of policies regarding 
substance use has. Thus, the latter may be an indispensable measure. Such 
interventions, which have demonstrated success, include increasing the age for 
alcohol consumption, restrictions on the amount of individuals allowed within an 
alcohol retailer, or reducing alcohol advertisements to name a few (Room, Babor & 
Rehm, 2005; Hope, 2006; Ferrell, 2016). Nonetheless, the findings reported on 
substance abuse herein highlight that similar interventions to reduce this addictive 
habit are urgently needed.  
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4.4. Infectious diseases 
While many studies have concluded cause of death as being cardiovascular and 
neurological in nature in SUDY cases, only a few have investigated cause of death 
from a South African stance. Comparable to local studies (du Toit-Prinsloo et al., 2011; 
Kruger, 2016; van Deventer, Rossouw & du Toit-Prinsloo, 2016), more than half of the 
cases had natural causes of death (Figure 3.10), out of which there was an 
overwhelming amount of infectious causes (64.9 %) (Figure 3.11). Pneumonia and TB 
were among the leading causes of death in all age categories (Appendix F), and the 
involvement of the pulmonary system in SUDY was comparable to both local 
(Tiemensma & Burger, 2012; van Deventer, Rossouw & du Toit-Prinsloo, 2016) and 
international studies (Amital et al., 2004).  
Infectious disease is a major cause for concern both locally and globally (Kruger, 2016; 
World Health Organization, 2019d). In 2017, pneumonia particularly was the prime 
cause of infectious death globally, accounting for 15 % of all deaths in children less 
than 5 years old (World Health Organization, 2019d). With pneumonia being a 
transmissible disease, research into the identification of pneumonic pathogens is vital 
to establish means to prevent and treat this condition. One such mean could be 
inoculation development, and in order for this to materialise, enhanced understanding 
of transmissible pathogens is necessary. Achieving this could potentially result from 
increasing ancillary testing to a full scope, which will contribute towards public health 
and ultimately reduce mortalities. However, given that numerous mortuaries in South 
Africa are resource-constrained (Mathews et al., 2016), this may be not be possible. 
In the current study, post-mortem histology had only occurred in 28.1 % of cases and 
microbiology in 5.8 % (Figure 3.9). Hence, these findings highlight the limited testing 
conducted and advocate for increased microbiological and histological ancillary 
investigations. Additionally, it prompts for these tests to become mandatory in the 
investigative process of cases of an infectious nature. This would lead to the 
identification of causative pathogens which can then be prioritised for inoculation 
development. The ultimate reduction of such fatalities via increasing immunity in the 
background population, aligns to the third SDG. Not only does this pertain to SUDY 
solely, but to all cases of SUD both locally and internationally. 
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4.5. Ill-defined causes of death 
Despite cause of death being defined in the majority of cases herein, the cause of 
death in many of the SUDY cases globally remains undetermined or ill-defined due to 
major inconsistencies in the DSI process and post-mortem examination of these 
deaths (Dewar et al., 2012). This is often a consequence of disparities in national 
standardised guidelines and non-compliance to policies and procedures (du Toit-
Prinsloo et al., 2013) - the CDC guidelines are an exception. Vital registration data 
published by Statistics South Africa in 2012 stated that there had been a fluctuation 
over the years in the number of fatalities noted as having “ill-defined and unknown 
causes” (Statistics South Africa, 2012). However, the number of undetermined cases 
in relation to these fatalities is unknown due to insufficient data capturing and 
reporting.  
Whilst a local study had contributed to this data from a Pretoria and Western Cape 
Eastern Metropole perspective (du Toit-Prinsloo et al., 2011), data from SRM was 
unknown. In light of this, a total of 23/833 (2.8 %) cases were identified in this study 
as undetermined following a full post-mortem examination (Figure 3.10).  
Molecular autopsies in a local setting are currently being developed to address and 
aid in defining cause of death, particularly in cases where the cause of death is 
undetermined. Resolving these cases will not only aid in providing closure, but the 
technique demonstrates potential in that results can also be used to screen and 
educate at-risk individuals who may be oblivious to their potentially fatal genetic 
predisposition (Burns et al., 2017). This concept would also apply to some natural 
cases where cause of death is cardiac-related or even unspecified. Cause of death 
had been deemed as natural but not specified in 3.6 % of cases in this study. Although 
the proportion is relatively small, the non-specific natural cases will likely remain. This 
is due to legislation stating that it is only necessary for forensic pathologists to decipher 
natural from unnatural death (National Health Act, No. 61 of 2003, 2003:s1). 
A molecular autopsy is a fairly novel subsidiary investigation that has shown value in 
cases with ill-defined causes of death, whereby the analysis of the DNA of the 
deceased individual has been able to pinpoint genetic variants which could explain the 
death (Farwell & Gollob, 2007; Campuzano et al., 2017; Hellenthal et al., 2017). The 
undetermined, under investigation, and non-specific natural cases herein were 
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henceforth identified as candidates for molecular autopsies in future investigations. 
Whilst biological sample retention is currently discretionary (National Health Act, No. 
61 of 2003, 2003:s1), fortunately 81.8 % (144/176) of candidate cases identified herein 
had samples available for future investigations (Figure 3.1). These samples included 
blood and FFPE tissue, as alternate samples had either not been retained or were 
discarded following other ancillary investigations. Although the percentage of retained 
samples was favourable herein, this may not always be the case due to its 
discretionary nature - a shortcoming of current protocols.  
To further emphasise the need for standardised procedures and subsequent 
compliance to procedures, the extent of post-mortem was also evaluated. In contrast 
to SUDC studies wherein a full post-mortem examination was performed in all cases 
(van Deventer, Rossouw & du Toit-Prinsloo, 2016), a full post-mortem examination 
was performed in only 54.7 % of cases herein. Due to Pretoria Medico-legal 
Laboratory not having a LODOX, it would have been necessary to draw conclusions 
on cause of death based on a full examination. However, the unique nature of each 
case suggests that it is not always necessary for further ancillary investigations to be 
conducted due to the discernible cause of death based on case history and radiology, 
hence the varying results. Although, even if cause of death is established, these tests 
would aid in gaining data to assist with the implementation of preventative measures 
and thereby contribute to enhanced public health. 
Nevertheless, with just over a third of cases herein having identified cause of death 
and organ system based on external examination and radiology alone, it is an area of 
concern in that inheritable conditions pertaining to these deaths may be overlooked. 
Radiology, however, is often performed solely as result of SRM being a resource-
constrained mortuary (Mathews et al., 2016). With subsidiary investigations being 
subsequently averted due to their discretionary nature, fatalities which could have 
otherwise been prevented in surviving relatives result. With a total of 40/661 (6.1 %) 
cases having had a family history with previous sudden death (Appendix E), this 
finding provides justification for a potential genetic link. However, the mandatory 
nature of LODOX at SRM provides justification for why it was the main ancillary 
investigation performed (95.6 %) while the remaining 4.4 % did not have a full-body 
scan due to equipment malfunctioning or maintenance.  
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4.6. Inheritable conditions 
All natural, undetermined and under investigation cases were assessed for risk factors 
to understand which organ systems were involved. One of the uses of this information 
is to identify molecular pathways to target in future molecular autopsies. With the 
majority of causes being transmissible or inheritable in nature, identifying these 
potential risks may assist in educating surviving relatives of a potential genetic 
predisposition, therapeutic measures to implement, and social and clinical aspects to 
be cautious of, thus possibly reducing mortality (Anastasakis et al., 2018).  
Overall, the main organ systems involved in these cases were the pulmonary, CVS, 
CNS and GIT which parallels international trends (Vennemann et al., 2007; Grønborg 
& Uldall, 2014). Whilst these are the main organ systems necessary for survival, the 
leading exact causes of death (Figure 3.12) contrasted international studies. There 
were 29/485 (6.0 %) cases that had an overlap in systems, specifically the pulmonary 
and CVS. Vomiting was identified as one of the leading symptoms in all age categories 
accounting for more than a quarter of cases (163/540; 30.2 %). In the 1-10 year age 
category specifically, other leading symptoms to have transpired prior to/at death were 
fever (21/63; 33.3 %) and diarrhoea (19/63; 30.2 %) (Figure 3.18). Moreover, a 
medical history of TB and HIV exposure were also well-noted in this age group and 
31-40 year olds. These symptoms and medical histories thus allude to the main organ 
systems involved in death and should stand as warning signs for caregivers and 
healthcare workers considering that majority of cases occurred in residential locations 
and medical centres (Figure 3.8). 
Closer observation of CVS deaths showed that the majority of these cases had non-
specific cardiovascular causes (Figure 3.12). However, when specified, myocardial 
infarction and ischaemic heart disease were the leading causes which is similar to 
previous studies of SCD (Maron et al., 2014; Rao et al., 2014). Additional 
cardiovascular causes were coronary artery thrombosis and hypertensive heart 
disease. These cardiac conditions are all well-known for having genetic associations 
(Maron et al., 2000; Anastasakis et al., 2018). There was no significant difference 
between males and females for each cause noted in any of the cardiac conditions nor 
the remaining identified causes of death. However, the following question arises: “why 
do these cardiovascular cases specifically get referred to us and others not?”. In order 
to provide explanations to this question, it is necessary to collate this data with other 
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vital statistics and mortality data from a non-forensic setting – an area of research to 
be fulfilled. 
While only a small number demised due to physical exertion, when death ensued, 
there was a significant association to a comprised CVS (7/8; 87.5 %) (p = 0.011). 
Furthermore, there were significantly more males who had engaged in physical activity 
compared to females (p < 0.001). These individuals were aged between 17-39 years. 
This finding is of potential value for future research as a previous study by Amital et 
al. (2004) indicated that physical activity was a potential risk for SCD. 
With the leading symptom in individuals > 11 years being breathlessness and chest 
pain (Figure 3.16), which parallels international trends (Gullach et al., 2015), further 
allusion to organ systems and cardiovascular diseases specifically results. 
Statistically, significantly more males than females in the age group of 31-40 years 
were located outdoors at death (p < 0.001). Hence, perhaps males present at outdoor 
sporting facilities, who are genetically predisposed to cardiovascular conditions and 
demonstrate symptoms of breathlessness and chest pain, could potentially be 
targeted for screening. Screening and therapeutic interventions have shown positive 
outcomes for these individuals internationally (Semsarian & Hamilton, 2012; 
Anastasakis et al., 2018) and could thus subsequently be implemented. However, 
further studies should be performed to elucidate this finding due to the marginal 
proportion of these cases. 
The leading cause of death in South Africans after Human Immunodeficiency Virus 
(HIV) is cardiovascular disease which is responsible for every 1 in 6 deaths (Byrne, 
Eksteen & Crickmore, 2016). Hence gaining insight into the molecular pathways 
involved in cardiovascular deaths and screening individuals with a history of heart 
disease in either family or medical history would be of utmost importance (Anastasakis 
et al., 2018). In our local context, these molecular findings would be considerable for 
public health as South Africa is home to individuals of African and Admixed ancestries 
(Daya et al., 2013; Nel, 2017). Within the population groups, factors may differ 
genetically from the rest of the world and thus interventions should align (Daya et al., 
2013). 
Although neurological conditions were identified herein to a lesser extent compared to 
literature, epilepsy and mental disease were prevalent in 11-20 year olds, whereas TB 
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exposure and epilepsy were prevalent in the 21-30 year category (Figure 3.17). 
Moreover, the overall low percentage of epilepsy cases (2.7 %) identified herein 
contradicts international findings wherein SUDEP was the common cause of death 
(Table 1.3). 
In light of epilepsy being the common cause of SUD internationally, resources were 
directed at SUDEP. However, based on the genetically diverse population within South 
Africa (Daya et al., 2013), the low percentage of SUDEP may be attributed to an 
overwhelming number of infectious causes. Furthermore, given that SUDEP is a multi-
factorial disease, it is possible that environmental differences may play a role (The 
University of Chicago Medical Center, 2020). It is also possible that these neurological 
conditions are being overlooked due to the partial or external scope of autopsy, for 
example where compounding factors are identified via routine toxicology or where 
neuropathological lesions, contusions  or malformations are presented via brain 
cutting (Thom & Allinson, 2019). Hence, a mandatory full post-mortem examination 
may be beneficial in SUDY cases. Taking these inheritable neurological conditions 
into account and reviewing neurotrophin signalling pathways (Ozdemir et al., 2019) 
would add to global data on molecular autopsies from a South Africa stance. However, 
directing resources at infections, cardiovascular causes and the substance abuse 
crisis within South Africa may be of greater value. 
 
4.5. Limitations and discrepancies 
Engaging with secondary data has inherent errors which cannot necessarily be 
rectified. Due to the retrospective and cross-sectional nature of this study, cases had 
missing documentation or information. This sub-optimal completion of paperwork may 
be due to several factors including the vast caseload experienced at forensic 
mortuaries in South Africa, the length and sensitive nature of the family interviews as 
well as possible inadequate training of investigative officers due to resource 
constraints (Mathews et al., 2016). These limitations advocate for training of Forensic 
Pathology Officers to ensure compliance to standardised procedures.  
Although the study period was 2016-2018, only 581/833 (67.9 %) cases had 
documented alleged cause of death based on the availability of the final post-mortem 
reports. This is significant from an operational stance and warrants further 
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investigation to identify why these cases are not being resolved within a three-year 
period. It is especially important in SUDY cases as there may be a familial or inherited 
disease and the findings could be relevant for surviving relatives. In addition, since 
only 438/704 (62.2 %) cases had full and partial post-mortem examinations performed 
cumulatively, this depicts that exact diagnosis was not confirmed in almost 40 % of 
cases. Had there been greater performance of ancillary investigations, such as 
toxicology, histology and microbiology investigations, more exact causes of death 
would have been identified leaving less cases for molecular autopsies and thus this 
operational limitation could have potentially been addressed. 
It was previously noted that language barriers have also hampered abilities to obtain 
sufficient details of cases during family interviews (Tiemensma & Burger, 2012), 
especially in multi-lingual countries such as South Africa. Although language barriers 
were not investigated herein, this may be a potential justification for lack of information 
obtained in numerous cases. Additionally, had more information been gathered on 
circumstances surrounding death in these cases, cases that were initially reported as 
SUD but later identified as unnatural death could have been correctly noted as such 
upon entry to the mortuary. This further highlights a potential oversight from an 
operational viewpoint.  
In unidentified cases, contact had not been made with a next-of-kin and thus social 
and clinical history remained unknown. Furthermore, parallel to local survey results, 
personal factors such as income was not documented in a large proportion of cases 
(Reddy et al., 2010). A total of 51/833 cases either had missing identity documents or 
the deceased was unknown, thus the assumed age was taken as per the 
Contemporaneous Notes: Lab 27. Additionally, in 15.5 % (129/833) of SUDY cases, 
post-mortem reports were unavailable due to ongoing and inconclusive cases.  
Lastly, based on the choice of age categories, hindrances were experienced when 
comparing findings literature. Thus, re-grouping in five-year age intervals may be 
preferential for future research in order to aid international comparisons. 
 
4.8. Conclusion 
In essence, it is evident that individuals aged 31 ± 10.3 years with co-morbidities and 
who engaged with substances of abuse were the most vulnerable for SUDY. The 
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cause of death in these cases was most likely of an infectious nature. Given the 
imminent substance abuse crisis within our country, interventions targeted at the youth 
should be implemented in SUDY hotspots, in an attempt to reduce this risk factor.  
While in all age categories, majority of cases had no known prior illnesses or family 
history (Figure 3.17-3.18), many individuals showed symptoms of vomiting and 
breathlessness prior to death (Figure 3.16). These results suggest public awareness 
aimed at the social arena, sporting centres, and amongst caregivers and healthcare 
works needs to be raised to recognise early symptoms in our young. If observed, they 
should seek medical aid immediately. 
This study has also highlighted the value of ancillary investigations performed in these 
SUDY cases, specifically toxicology, histology, microbiology, and molecular assays. 
Given the resource-constraints prevalent in South African mortuaries (Mathews et al., 
2016), perhaps molecular assays would be preferential due to the inheritable and 
transmissible nature of infectious diseases. The findings herein also provide basis to 
advocate for adaptations to be made to standard operating procedures - to ensure that 
these investigations become mandatory in the post-mortem examination process of 
SUD. Additionally, it has accentuated the need for biological sample retention to 
become incumbent on law so as to aid in defining cause of death in ill-defined and 
undetermined cases. With cases having missing information and documentation, 
advocation for individuals to receive training to ensure compliance is warranted. 
Furthermore, operational aspects should be reviewed to address the operational 
limitations in terms of collecting information regarding the circumstances surrounding 
death. 
With a SDY-CR having been implemented internationally and demonstrated 
effectiveness in monitoring SCD and SUDEP cases below the ages of 20 years 
(Centers for Disease Control and Prevention, 2016), perhaps a similar concept or 
registry should be established in our local context. This potential registry should be 
devised to include individuals aged 1-40 years and should be directed at infections, 
cardiovascular conditions, and the substance abuse crisis in South Africa in light of 
the findings presented herein. Moreover, while the CDR is the ‘gold standard’ in the 
Western Cape for cases aged < 18 years (Mathews et al., 2016), a ‘Young Death 
Review’ team should be devised to aid in the further exploration of the cause of death 
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and risk factors pertaining to our young. A DSI protocol could subsequently be 
formulated to address these SUDY cases specifically since DSI protocols have not 
been well-established locally (Bennett, Martin & Heathfield, 2019). 
In conclusion, this project has highlighted the burden and profile of SUDY cases 
admitted to SRM between 1 January 2016 and 31 December 2018 thereby achieving 
the aim of this research project and adding to a growing body of literature from a South 
African stance. 
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APPENDIX C: DESCRIPTION OF DOCUMENTATION REVIEWED IN 
DATA COLLECTION PROCESS 
DOCUMENTS CONTENT 
Identification Document (ID)/birth certificate Unique identity number which includes date of birth, 
sex and country of birth.  
FPS 002 Scene Script Scene derails including preliminary manner of death 
and SAPS station. 
‘Contemporaneous Note (Lab. 27): Salt River Forensic 
Pathology Laboratory’ 
Basic details surrounding death. 
FPS 006(a) form Clinical and clinical history for adults attained at family 
interview including substance use, type of housing, 
medical history and family history. 
FPS 006(b) form Clinical and clinical history for babies attained at family 
interview, including substance use, type of housing, 
medical history and family history, maternal level of 
education and annual household income. 
‘South African Police Service (SAPS) sudden and 
unexpected death in adults’ 
Clinical and clinical history for adults attained at family 
interview including type of housing. 
Road to Health Card Information regarding HIV exposure. 
‘Affidavit in terms of Section 212(4), Act 51 of 1977’ Post-mortem report generated by the Forensic 
Pathologist which summarises the main post-mortem 
findings including the extent of post-mortem and 
ancillary investigations conducted, as well as 
stipulated manner and alleged cause of death. 
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APPENDIX D: DATA COLLECTION VARIABLE TABLE 
VARIABLE 
NUMBER 
VARIABLE VARIABLE TYPE METHOD OF DATA CAPTURE 
ALL CASES 
v1 Unique study number Categorical nominal xxxx/yyyy 
v2 Date of death declaration Categorical nominal dd/mm/yyyy 
PROFILE 
v3 SAPS Station Categorical nominal Free text 
DEMOGRAPHICS 
v4 Age (years) Numerical continuous Range (1-40) 
v5 Sex  Categorical binary Drop-down 
- Male 
- Female  
POST-MORTEM DETAILS 
v6 Date of post-mortem Categorical nominal dd/mm/yyyy 
v7 Extent of post-mortem 
 










- Other (Specify: _____) 
v9 LODOX 
(yes/no/unknown) 




CIRCUMSTANCES SURROUNDING DEATH 
v10 Location of death 
 
Categorical nominal Drop-down 
- Residential 
- Outdoors 
- Medical centre 
- Workplace 
- Jail 
- Motor vehicle 
- Sports ground 
- Unknown 
- Farming centre 
- Educational facility 
- Other (Specify:_______) 
v11 Position of deceased at 
death 
Categorical nominal Drop-down 
- Prone 
- Supine 
- Other (Specify:______) 
- Not specified 






- Other (Specify:_______) 
- Unknown (not witnessed) 
- Not specified 
 




VARIABLE VARIABLE TYPE METHOD OF DATA CAPTURE 
ALL CASES 
CAUSE OF DEATH 
v13 Manner of death Categorical nominal Coding 
0 - Unnatural  
1 - Natural 
2 - Undetermined 
3 - Under investigation 
4 – Unknown (missing) 
If 0 > v14 only 
If 1 > v14 
If 2 or 3 > v16 
v14 Exact cause of death Categorical nominal Free text - as reported by 
pathologist. 
v15 Organ system Categorical nominal Drop-down 
- Cardiovascular 
- Central nervous system 
- Pulmonary 
- Gastrointestinal 
- Other (Specify: ______) 
NATURAL, UNDETERMINED AND UNDER INVESTIGATION ONLY 
SOCIAL HISTORY 
v16 Highest level of 
education of mother 









v18 Annual household 
income 
Categorical nominal Free text – as per FPS006a 
form. 
v19 Did the deceased 
engage with any of 
the following 
substances? 
Categorical nominal Tick-box 
– Alcohol 
- Illicit drugs 
- Tobacco products 
- Pharmaceutical products 




v20 Did the deceased 








v21 Symptoms prior to 
death 
Categorical nominal Drop-down 
- None  
- Unknown (not witnessed) 
- Chest pain 
- Fitting 
- Holding head in pain 
- Abdominal pain 
- Severe headaches 
- Nose bleeds 
- Foaming at mouth 
- Breathlessness 
- Paralysis of limbs 
- Vomiting 
- Diarrhoea 
- Other (Specify:______) 




VARIABLE VARIABLE TYPE METHOD OF DATA CAPTURE 
NATURAL, UNDETERMINED AND UNDER INVESTIGATION ONLY 
CLINICAL HISTORY CONTINUED 
v22 Chronic illness/acute 
illness/ infection 
during lifetime 





- High blood pressure 
- Heart problems 
- Kidney problems 
- HIV exposure 
- TB exposure 
- Allergies 
- Mental disease 
- Malaria 
- Other (Specify: _____) 
- None 




If yes, specify:______ 
v24 Family history of 
illness 
Categorical nominal Tick-box 




- Sudden death 
- Other (Specify:______) 
- None 
- Unknown 
NON-SPECIFIC NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES 
OTHER 
v25 Are biological 
samples available? 
(yes/no) 
Categorical binary Drop-down 
- No 
- Yes 
If yes, specify:______ 
UNDETERMINED CASES ONLY 
v26 Was the body 
identified (yes/no) 
Categorical binary Drop-down 
- No 
- Yes 
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APPENDIX E: FULL VARIABLE LIST 
ALL CASES 
PROFILE 
Day of week n % of available data (n=833) 
Monday 144 17.3 
Tuesday 130 15.6 
Wednesday 91 10.9 
Thursday 118 14.2 
Friday 103 12.4 
Saturday 111 13.3 
Sunday 136 16.3 
Month of year n % of available data (n=833) 
January 64 7.7 
February 60 7.2 
March 62 7.4 
April 68 8.2 
May 58 7.0 
June 79 9.5 
July 72 8.6 
August 61 7.3 
September 74 8.9 
October 75 9.0 
November 79 9.5 
December 81 9.7 
 
 




SAPS station n % of available data (n=833) 
Nyanga 121 14.5 
Gugulethu 78 9.4 
Milnerton 62 7.4 
Mitchells Plain 61 7.3 
Woodstock 45 5.4 
Phillippi-East 44 5.3 
Cape Town Central 34 4.1 
Atlantis 33 4.0 
Grassy Park 32 3.8 
Lentegeur 26 3.1 
Seapoint 25 3.0 
Manenberg 23 2.8 
Ocean View 21 2.5 
Table View 21 2.5 
Athlone 20 2.4 
Wynberg 20 2.4 
Muizenberg 19 2.3 
Langa 18 2.2 
Kirstenhof 17 2.0 
Philippi 17 2.0 
Hout Bay 16 1.9 
Steenberg 12 1.4 
Mowbray 10 1.2 
Claremont 9 1.1 
Diep River 9 1.1 




SAPS station continued n % of available data (n=833) 
Lansdowne 9 1.1 
Maitland 8 1.0 
Simonstown 5 0.6 
Fish Hoek 3 0.4 
Kensington 3 0.4 
Rondebosch 3 0.4 
Camps Bay 2 0.2 
Pinelands 2 0.2 
Strandfontein 2 0.2 
Harare 1 0.1 
Melkbos 1 0.1 
Table Bay Harbour 1 0.1 
DEMOGRAPHICS 
Ages (years) n % of available data (n=833) 
1 41 4.9 
2 11 1.3 
3 7 0.8 
4 8 1.0 
5 4 0.5 
6 1 0.1 
7 4 0.5 
8 3 0.4 
9 3 0.4 
10 4 0.5 
11 5 0.6 




Ages (years) continued n % of available data (n=833) 
12 2 0.2 
13 2 0.2 
14 5 0.6 
15 3 0.4 
16 6 0.7 
17 8 1.0 
18 15 1.8 
19 6 0.7 
20 13 1.6 
21 15 1.8 
22 8 1.0 
23 21 2.5 
24 19 2.3 
25 21 2.5 
26 25 3.0 
27 28 3.4 
28 32 3.8 
29 42 5.0 
30 51 6.1 
31 41 4.9 
32 54 6.5 
33 43 5.2 
34 52 6.2 
35 54 6.5 
36 42 5.0 




Ages (years) continued n % of available data (n=833) 
37 47 5.6 
38 35 4.2 
39 41 4.9 
40 11 1.3 
Sex n % of available data (n=833) 
Males 536 64.3 
Females 297 35.6 
POST-MORTEM DETAILS 
Extent of post-mortem n % with missing data (n=833) % of available data (n=704) 
Full 385 46.2 54.7 
External 266 31.9 37.8 
Partial 53 6.4 7.5 
Unknown 129 15.5 - 
Ancillary investigations n % with missing data (n=833) % of available data (n=704) 
None 1 0.1 0.1 
Toxicology 205 24.6 29.1 
Histology 198 23.8 28.1 
Microbiology 41 4.9 5.8 
Biochemistry, Mast cell tryptase 1 0.1 0.1 
Full blood count, Urea and electrolytes, 
Liver function test 
1 0.1 0.1 
Genetics 1 0.1 0.1 
Mast cell tryptase 4 0.5 0.6 
Mast cell tryptase, IgE level 1 0.1 0.1 
Neuropathology 4 0.1 0.1 
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ALL CASES 
POST-MORTEM DETAILS CONTINUED 
Ancillary investigations n % with missing data (n=833) % of available data (n=704) 
Platelet count, Urea & creatinine level 1 0.1 0.1 
Protein C & S testing 1 0.1 0.1 
Urea & creatinine level 1 0.1 0.1 
Full blood count, Urea & creatinine level 1 0.1 0.1 
White cell count, Urea & creatinine level 1 0.1 0.10 
Unknown 129 15.5 - 
LODOX n % with missing data (n=833) % of available data (n=704) 
Yes 673 80.08 95.6 
No 31 3.7 4.4 
Unknown 129 15.5 - 
CIRCUMSTANCES SURROUNDING DEATH 
Location at death n % with missing data (n=833) % of available data (n=832) 
Residential 362 43.5 43.5 
Medical centre 292 35.1 35.1 
Outdoors 96 11.5 11.5 
Ambulance 15 1.8 1.8 
Jail 12 1.4 1.4 
Undertaker 11 1.3 1.3 
Transport-related 11 1.3 1.3 
Workplace 8 1.0 1.0 
Fire station 6 0.7 0.7 
Sports ground 3 0.4 0.4 
Educational facility 3 0.4 0.4 
Shop-related 3 0.4 0.4 
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ALL CASES 
CIRCUMSTANCES SURROUNDING DEATH CONTINUED 
Location at death continued n % with missing data (n=833) % of available data (n=832) 
Industrial facility 3 0.4 0.4 
Convention centre 2 0.2 0.2 
Lodging facility 2 0.2 0.2 
Financial institution 1 0.1 0.1 
Pub 1 0.1 0.1 
Farming centre 1 0.1 0.1 
Unknown 1 0.1 - 
Position at death n % with missing data (n=833) % of available data (n=452) 
Not specified 381 - 84.3 
Supine 303 45.7 67.0 
Prone 66 36.4 14.6 
Side 61 7.9 13.5 
Sitting 14 7.3 3.1 
Other 8 1.7 1.8 
Activity at death n % with missing data (n=833) % of available data (n=308) 
Not specified 372 - 44.7 
Sleeping 176 21.1 57.1 
Resting 79 9.5 25.6 
Walking 21 2.5 6.8 
Exercising 7 0.8 2.3 
Bathroom-related 7 0.8 2.3 
Playing 5 0.6 1.6 
Religious/cultural 3 0.4 1.0 
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ALL CASES 
CIRCUMSTANCES SURROUNDING DEATH CONTINUED 
Activity at death continued n % with missing data (n=833) % of available data (n=308) 
Cooking/cleaning 3 0.4 1.0 
Driving 2 0.2 0.6 
Dancing 2 0.2 0.6 
Climbing 1 0.1 0.3 
Firefighting 1 0.1 0.3 
Moving tiles 1 0.1 0.3 
Unknown 153 18.4 - 
CAUSE OF DEATH 
Manner of death n % with missing data (n=833) % of available data (n=704) 
Unnatural 43 5.2 6.1 
Natural 515 61.8 73.2 
Under investigation 122 14.6 17.3 
Undetermined 23 2.8 3.3 
Unknown (missing) 128 15.4 - 
Exact cause of death n % with missing data (n=833) % of available data (n=704) 
Unknown (missing) 129 15.5 18.3 
Under investigation 123 14.8 17.5 
Pneumonia 50 6.0 7.1 
TB 45 5.4 6.4 
Cardiovascular pathology 38 4.6 5.4 
Respiratory Pathology 34 4.1 4.8 
Natural (not specified) 30 3.6 4.3 
Lung disease 26 3.1 3.7 
Undetermined 23 2.8 3.3 
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ALL CASES 
CAUSE OF DEATH CONTINUED 
Exact cause of death continued n % with missing data (n=833) % of available data (n=704) 
Cardiorespiratory pathology 21 2.5 3.0 
Ischaemic heart disease 18 2.2 2.6 
Myocardial infarction 18 2.2 2.6 
Meningitis 16 1.9 2.3 
Pulmonary embolism 16 1.9 2.3 
Blunt trauma 13 1.6 1.8 
Epilepsy 13 1.6 1.8 
Coronary artery thrombosis 12 1.4 1.7 
Diarrhoea & Dehydration 12 1.4 1.7 
Pulmonary infection 12 1.4 1.7 
Aspiration of gastric contents/airway obstruction 9 1.1 1.3 
Perforated gastrointestinal ulcer 7 0.8 1.0 
Alcohol toxicity 6 0.7 0.9 
Hypertensive heart disease 6 0.7 0.9 
Noxious substance 6 0.7 0.9 
Pancreatitis 6 0.7 0.9 
Cysticercosis 5 0.6 0.7 
Gastroenteritis 5 0.6 0.7 
Haemoptysis 5 0.6 0.7 
Liver pathology 5 0.6 0.7 
Ruptured berry aneurysm 4 0.5 0.6 
Asthma 3 0.4 0.4 
Cardiac tamponade 3 0.4 0.4 
Cardiomyopathy 3 0.4 0.4 
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ALL CASES 
CAUSE OF DEATH CONTINUED 
Exact cause of death continued n % with missing data (n=833) % of available data (n=704) 
Diabetes 3 0.4 0.4 
Intestine disease 3 0.4 0.4 
Sepsis 3 0.4 0.4 
Cardiomegaly 2 0.2 0.3 
HIV 2 0.2 0.3 
Infection. HIV 2 0.2 0.3 
Intracerebral haemorrhage 2 0.2 0.3 
Medical negligence 2 0.2 0.3 
Myocarditis 2 0.2 0.3 
Perforated appendix 2 0.2 0.3 
Peritonitis 2 0.2 0.3 
Pneumothorax 2 0.2 0.3 
Sharp trauma 2 0.2 0.3 
Cardiovascular pathology. abdominal disease 1 0.1 0.1 
Renal disease 1 0.1 0.1 
Abdominal pathology. HIV 1 0.1 0.1 
Anaemia 1 0.1 0.1 
Anaphylactic shock 1 0.1 0.1 
Aortic aneurysm 1 0.1 0.1 
Arrythmia 1 0.1 0.1 
Bleeding diathesis with anaemia 1 0.1 0.1 
Bowel torsion 1 0.1 0.1 
Brain disease 1 0.1 0.1 
Brain tumour 1 0.1 0.1 
 
Page | 78 of 125 
 
ALL CASES 
CAUSE OF DEATH CONTINUED 
Exact cause of death continued n % with missing data (n=833) % of available data (n=704) 
Brain tumour. abdominal abscess 1 0.1 0.1 
Bronchiectasis 1 0.1 0.1 
Cardiovascular pathology. Lung disease 1 0.1 0.1 
Cerebellar abscess 1 0.1 0.1 
Cerebral pathology 1 0.1 0.1 
Cerebrovascular accident 1 0.1 0.1 
Collapsed lung. diabetes 1 0.1 0.1 
Complications of pregnancy. hypertension 1 0.1 0.1 
Congenital heart disease 1 0.1 0.1 
Congestive heart failure. Bronchiectasis 1 0.1 0.1 
Coronary artery aneurysm 1 0.1 0.1 
Coronary artery atherosclerosis 1 0.1 0.1 
Coronary artery disease. Infection 1 0.1 0.1 
Diabetes. Respiratory pathology 1 0.1 0.1 
Drowning 1 0.1 0.1 
Eroded feeding tube 1 0.1 0.1 
Gastritis 1 0.1 0.1 
Gastrointestinal haemorrhage 1 0.1 0.1 
Gastrointestinal pathology 1 0.1 0.1 
Gastro-intestinal sepsis and skin infection 1 0.1 0.1 
Haemoptysis. Epilepsy 1 0.1 0.1 
Haemorrhagic pneumonia 1 0.1 0.1 
Haemorrhagic stroke 1 0.1 0.1 
Haematological in nature 1 0.1 0.1 
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ALL CASES 
CAUSE OF DEATH CONTINUED 
Exact cause of death continued n % with missing data (n=833) % of available data (n=704) 
Heart failure 1 0.1 0.1 
Heat stroke 1 0.1 0.1 
Hypertension 1 0.1 0.1 
Hyperthermia 1 0.1 0.1 
Hypothermia. TB 1 0.1 0.1 
Idiopathic hydrocephalus 1 0.1 0.1 
Infarcted brain. Cardiovascular pathology 1 0.1 0.1 
Infection (non-specific) 1 0.1 0.1 
Intestinal bowel obstruction 1 0.1 0.1 
Intestinal torsion 1 0.1 0.1 
Intracranial haemorrhage 1 0.1 0.1 
Ischaemic bowel disease 1 0.1 0.1 
Ischaemic cerebral infarct. HIV 1 0.1 0.1 
Left lung abscess 1 0.1 0.1 
Meningo-encephalitis 1 0.1 0.1 
Myocardial infarction. Pneumonia 1 0.1 0.1 
Perforated spleen 1 0.1 0.1 
Pericarditis 1 0.1 0.1 
Pneumonia. Cardiomyopathy 1 0.1 0.1 
Pneumonia. Dehydration 1 0.1 0.1 
Pneumonia. diarrhoea 1 0.1 0.1 
Pneumonia. Myocarditis 1 0.1 0.1 
Polycystic renal disease 1 0.1 0.1 
Post varicella zoster toxic shock syndrome 1 0.1 0.1 
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ALL CASES 
CAUSE OF DEATH CONTINUED 
Exact cause of death continued n % with missing data (n=833) % of available data (n=704) 
Post-partum haemorrhage 1 0.1 0.1 
Renal disease 1 0.1 0.1 
Rheumatic heart disease 1 0.1 0.1 
Ruptured aneurysm of  pulmonary trunk 1 0.1 0.1 
Ruptured ectopic pregnancy 1 0.1 0.1 
Saddle embolism 1 0.1 0.1 
Sigmoid volvulus 1 0.1 0.1 
Skin wounds 1 0.1 0.1 
Smoke inhalation 1 0.1 0.1 
Strangulation 1 0.1 0.1 
Subarachnoid haemorrhage 1 0.1 0.1 
Subclavian-aortic bypass graft 1 0.1 0.1 
Subdural empyema 1 0.1 0.1 
Syphilitic meso-aortitis 1 0.1 0.1 
T-Cell lymphoma 1 0.1 0.1 
Thymic tumour 1 0.1 0.1 
Thyroid mass 1 0.1 0.1 
Tonsillitis 1 0.1 0.1 
Tonsillitis. Sepsis 1 0.1 0.1 
Urinary tract infection 1 0.1 0.1 
Viral infection (cardiovascular) 1 0.1 0.1 
Viral myocarditis 1 0.1 0.1 
Viral myocarditis. Pneumonia 1 0.1 0.1 
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ALL CASES 
CAUSE OF DEATH CONTINUED 
Infectious or non-infectious n % with missing data (n=833) % of available data (n=704) 
Infectious 315 37.8 44.7 
Non-infectious 170 20.4 24.1 
Not specified 30 3.6 4.3 
Unknown 129 15.5 - 
Organ system n % with missing data (n=833) % of available data (n=704) 
Pulmonary 235 28.2 34.9 
Cardiovascular 153 18.4 22.7 
Central nervous system 54 6.5 8.0 
Gastrointestinal 50 6.0 7.4 
Multiple 11 1.3 1.6 
Urinary 9 1.1 1.3 
Lymphatic 7 0.8 1.0 
Endocrine 7 0.8 1.0 
Reproductive 3 0.4 0.4 
Integumentary 2 0.2 0.3 
Unknown 129 15.5 - 
 
NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
SOCIAL HISTORY 
Maternal level of education All Males Females 
 n % with missing data (n=66) % of available data (n=34) n n 
Secondary (Grades 8-12) 31 47.0 91.2 20 11 
Primary (Grades 1-7) 3 4.5 8.8 3 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
SOCIAL HISTORY CONTINUED 
Maternal level of education 
continued 
All Males Females 
 n % with missing data (n=66) % of available data (n=34) n n 
Unknown 32 48.5 - 16 16 
Types of housing All Males Females 
 n % with missing data (n=66) % of available data (n=44) n n 
Formal 23 34.8 52.3 15 8 
Informal 21 31.8 47.7 12 9 
Unknown 22 33.3 - 12 10 
Annual Household income All Males Females 
South African Rands n % with missing data (n=66) % of available data (n=44) n n 
0 3 4.5 6.8 1 2 
9 600 1 1.5 2.3 1 0 
24 000 1 1.5 2.3 1 0 
31 200 1 1.5 2.3 1 0 
54 000 1 1.5 2.3 1 0 
78 000 1 1.5 2.3 1 0 
96 000 1 1.5 2.3 1 0 
120 000 1 1.5 2.3 1 0 
Not specified 23 34.8 - 15 8 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
SOCIAL HISTORY CONTINUED 
Substances of abuse All Males Females 
 n % with missing data (n=66) % of available data (n=64) n n 
None 63 95.5 98.4 37 26 
Alcohol 0 0.0 0.0 0 0 
Tobacco 1 1.5 1.6 0 1 
Illicit drugs 0 0.0 0.0 0 0 
Unknown 2 3.0 3.1 2 0 
Specific substances All Males Females 
 n % with missing data (n=66) % of available data (n=1) n n 
Not specified 1 1.5 100.0 1 0 
Physical activity All Males Females 
 n % with missing data (n=66) % of available data (n=66) n n 
Yes 0 0 0 0 0 
Unknown 66 100 - 39 27 
CLINICAL HISTORY 
Symptoms prior to death All Males Females 
 n % with missing data (n=66) % of available data (n=63) n n 
Vomiting 29 43.9 46.0 16 13 
Fever 21 31.8 33.3 13 8 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
CLINICAL HISTORY CONTINUED 
Symptoms prior to death continued All Males Females 
 n % with missing data (n=66) % of available data (n=63) n n 
Diarrhoea 19 28.8 30.2 12 7 
Breathlessness 16 24.2 25.4 7 9 
Coughing 14 21.2 22.2 13 1 
Fitting 12 18.2 19.0 8 4 
Runny nose 9 13.6 14.3 8 1 
Abdominal pain 8 12.1 12.7 3 5 
Foaming at mouth 6 9.1 9.5 1 5 
Severe headaches 6 9.1 9.5 2 4 
Paralysis of limbs 4 6.1 6.3 2 2 
Difficulty swallowing 4 6.1 6.3 2 2 
None 3 4.5 4.8 3 0 
Blood from mouth 3 4.5 4.8 2 1 
Stiff neck 3 4.5 4.8 2 1 
Chest pain 2 3.0 3.2 2 0 
Nose bleeds 1 1.5 1.6 0 1 
Abdominal distension 1 1.5 1.6 0 1 
Dizzy 1 1.5 1.6 0 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
CLINICAL HISTORY CONTINUED 
Symptoms prior to death continued All Males Females 
 n % with missing data (n=66) % of available data (n=63) n n 
Mucus from nose 1 1.5 1.6 0 1 
Swollen neck/face 1 1.5 1.6 1 0 
Crying 1 1.5 1.6 0 1 
Not specified 2 3.0 - 1 1 
Unknown (not witnessed) 1 1.5 - 1 0 
Chronic illness/acute 
illness/infection during lifetime 
All Males Females 
 n % with missing data (n=66) % of available data (n=66) n n 
None 29 43.9 43.9 18 11 
HIV exposure 7 10.6 10.6 4 3 
TB exposure 6 9.1 9.1 4 2 
Cerebral palsy 5 7.6 7.6 3 2 
Disability 4 6.1 6.1 2 2 
Epilepsy 3 4.5 4.5 1 2 
Sinus 3 4.5 4.5 3 0 
Mental disease 2 3.0 3.0 2 0 
Flu 2 3.0 3.0 1 1 
Lung problems 2 3.0 3.0 2 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
CLINICAL HISTORY CONTINUED 
Chronic illness/acute 
illness/infection during lifetime 
continued 
All Males Females 
 n % with missing data (n=66) % of available data (n=66) n n 
Jaundice 2 3.0 3.0 1 1 
Stomach bug 2 3.0 3.0 1 1 
Asthma 1 1.5 1.5 1 0 
Heart problems 1 1.5 1.5 0 1 
Kidney problems 1 1.5 1.5 1 0 
Septic wounds 1 1.5 1.5 1 0 
Pneumonia 1 1.5 1.5 1 0 
Malnutrition 1 1.5 1.5 1 0 
Bronchitis 1 1.5 1.5 1 0 
Abdominal pain 1 1.5 1.5 1 0 
Chicken pox 1 1.5 1.5 0 1 
Toothache 1 1.5 1.5 0 1 
Sore throat 1 1.5 1.5 0 1 
Down syndrome 1 1.5 1.5 0 1 
Ear infection 1 1.5 1.5 1 0 
Parotitis 1 1.5 1.5 0 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
CLINICAL HISTORY CONTINUED 
Chronic illness/acute 
illness/infection during lifetime 
continued 
All Males Females 
 n % with missing data (n=66) % of available data (n=66) n n 
Cytomegalovirus infection 1 1.5 1.5 0 1 
Eczema 1 1.5 1.5 1 0 
Growth problems 1 1.5 1.5 0 1 
Hydrocephalus 1 1.5 1.5 0 1 
High blood sugar 1 1.5 1.5 1 0 
Virus 1 1.5 1.5 0 1 
Meningitis 1 1.5 1.5 1 0 
Prada Willi Syndrome 1 1.5 1.5 1 0 
Pierre-Robinsons Syndrome 1 1.5 1.5 1 0 
Central Hyper Thyroidism 1 1.5 1.5 1 0 
Rubella 1 1.5 1.5 1 0 
Medicinal substance use All Males Females 
 n % with missing data (n=66) % of available data (n=65) n n 
Pharmaceutical products 42 63.6 64.6 25 17 
None 20 30.3 30.7 10 10 
Traditional medicine 3 4.5 4.6 2 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
CLINICAL HISTORY CONTINUED 
Medicinal substance use continued All Males Females 
 n % with missing data (n=66) % of available data (n=65) n n 
Unknown 3 4.5 - 3 0 
Chronic medication All Males Females 
 n % with missing data (n=66) % of available data (n=63) n n 
No 48 72.7 76.2 27 21 
Yes 15 22.7 23.8 9 6 
Unknown 3 4.5 - 3 0 
Medicinal substances All Males Females 
  n % with missing data (n=66) % of available data (n=66) n n 
Paracetamol 20 30.3 30.3 10 10 
Antibiotics 3 4.5 4.5 2 1 
Antiretrovirals 3 4.5 4.5 3 0 
Chlorpheniramine 3 4.5 4.5 1 2 
Cotrimoxazole 3 4.5 4.5 3 0 
Phenobarbital 3 4.5 4.5 3 0 
Allergy medication 2 3.0 3.0 2 0 
Pyrazinamide 2 3.0 3.0 2 0 
Pyridoxine 2 3.0 3.0 2 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
CLINICAL HISTORY CONTINUED 
Medicinal substances continued All Males Females 
 n % with missing data (n=66) % of available data (n=66) n n 
Acetylsalicylic  acid 1 1.5 1.5 1 0 
Amoxicillin, Clavulanic acid 1 1.5 1.5 1 0 
Cough medicine 1 1.5 1.5 1 0 
Diarrhoea tablet 1 1.5 1.5 1 0 
Diazepam 1 1.5 1.5 1 0 
Glucose 1 1.5 1.5 1 0 
Isotretinoin 1 1.5 1.5 1 0 
Jamaica ginger 1 1.5 1.5 1 0 
Lactobacillus acidoph-pectin 1 1.5 1.5 1 0 
Metoclopramide 1 1.5 1.5 1 0 
Multivitamin syrup 1 1.5 1.5 1 0 
Muti 1 1.5 1.5 1 0 
Nose drops 1 1.5 1.5 1 0 
Omeprazole 1 1.5 1.5 1 0 
Pramoxine 1 1.5 1.5 0 1 
Prescription medication 1 1.5 1.5 0 1 
Pyroxamine 1 1.5 1.5 1 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
CLINICAL HISTORY CONTINUED 
Medicinal substances continued All Males Females 
 n % with missing data (n=66) % of available data (n=66) n n 
Ritonavir 1 1.5 1.5 1 0 
Salbutamol 1 1.5 1.5 1 0 
Salt solution 1 1.5 1.5 1 0 
TB medication 1 1.5 1.5 0 1 
Teething syrup 1 1.5 1.5 1 0 
Umhlonyane 1 1.5 1.5 0 1 
Vitamin C 1 1.5 1.5 1 0 
Zinc tablets 1 1.5 1.5 0 1 
Not specified 2 3.0 - 0 2 
Family history of illness All Males Females 
 n % with missing data (n=66) % of available data (n=55) n n 
Unknown 11 16.7 - 7 4 
None 34 51.5 61.8 17 17 
HIV 9 13.6 16.4 9 0 
High blood pressure 8 12.1 14.5 4 4 
Previous sudden death 3 4.5 5.5 2 1 
Asthma 1 1.5 1.8 0 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 1 – 10 YEARS 
CLINICAL HISTORY CONTINUED 
Family history of illness 
continued 
All Males Females 
 n % with missing data (n=66) % of available data (n=55) n n 
Cancer 1 1.5 1.8 0 1 
 
NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 11 – 20 YEARS 
SOCIAL HISTORY 
Types of housing All Males Females 
 n % with missing data (n=51) % of available data (n=23) n n 
Formal 12 23.5 52.2 7 5 
Informal 11 21.6 47.8 5 6 
Unknown 28 54.9 - 10 18 
Substances of abuse All Males Females 
 n % with missing data (n=51) % of available data (n=44) n n 
None 31 60.8 70.5 11 20 
Alcohol 9 17.6 20.5 5 4 
Tobacco 6 11.8 13.6 4 2 
Illicit drugs 5 9.8 11.4 3 2 
Unknown 7 13.7 - 4 3 
Specific substances All Males Females 
 n % with missing data (n=51) % of available data (n=26) n n 
Ciders 1 2.0 3.3 0 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 11 – 20 YEARS 
SOCIAL HISTORY CONTINUED 
Specific substances continued All Males Females 
 n % with missing data (n=51) % of available data (n=26) n n 
Spirits 1 2.0 3.3 0 1 
Wine 1 2.0 3.3 0 1 
Beer 5 9.8 16.7 2 3 
Brandy 3 5.9 10.0 1 2 
Methamphetamine 2 3.9 6.7 0 2 
Cannabis 5 9.8 16.7 4 1 
Ecstasy 1 2.0 3.3 1 0 
Methaqualone 2 3.9 6.7 0 2 
Glue 1 2.0 3.3 1 0 
Cigarettes 4 7.8 13.3 3 1 
Hubbly 1 2.0 3.3 1 0 
Not specified 3 5.9 10.0 2 1 
Physical activity All Males Females 
 n % with missing data (n=51) % of available data (n=1) n n 
Yes 1 2.0 2.3 1 0 
Unknown 50 98.0 - 21 29 
CLINICAL HISTORY 
Symptoms prior to death All Males Females 
 n % with missing data (n=51) % of available data (n=39) n n 
Breathlessness 13 25.5 33.3 8 5 
Vomiting 13 25.5 33.3 8 5 
Foaming at mouth 10 19.6 25.6 3 7 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 11 – 20 YEARS 
CLINICAL HISTORY CONTINUED 
Symptoms prior to death 
continued 
All Males Females 
 n % with missing data (n=51) % of available data (n=39) n n 
Fitting 8 15.7 20.5 3 5 
Severe headaches 8 15.7 20.5 3 5 
Abdominal pain 7 13.7 17.9 4 3 
Diarrhoea 6 11.8 15.4 4 2 
Fever 5 9.8 12.8 5 0 
Nose bleeds 5 9.8 12.8 3 2 
Chest pain 4 7.8 10.3 1 3 
Paralysis of limbs 3 5.9 7.7 1 2 
Blood from mouth 2 3.9 5.1 1 1 
Abdominal distension 2 3.9 5.1 2 0 
Urinated 2 3.9 5.1 1 1 
Foaming at nose 2 3.9 5.1 0 2 
Salivating 2 3.9 5.1 1 1 
Coughing 1 2.0 2.6 1 0 
Vomiting blood 1 2.0 2.6 0 1 
Stiff neck 1 2.0 2.6 0 1 
Runny nose 1 2.0 2.6 0 1 
Nausea 1 2.0 2.6 1 0 
Leg pain 1 2.0 2.6 1 0 
Not specified 2 3.9 - 0 2 
Unknown (not witnessed) 10 19.6 - 3 7 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 11 – 20 YEARS 
CLINICAL HISTORY CONTINUED 
Chronic illness/acute 
illness/infection during lifetime 
All Males Females 
 n % with missing data (n=51) % of available data (n=45) n n 
None 23 45.1 51.1 7 16 
Epilepsy 6 11.8 13.3 2 4 
Mental disease 5 9.8 11.1 2 3 
TB exposure 2 3.9 4.4 0 2 
Obesity 2 3.9 4.4 0 2 
Flu 2 3.9 4.4 2 0 
Allergies 2 3.9 4.4 1 1 
Disability 2 3.9 4.4 1 1 
Cerebral palsy 2 3.9 4.4 1 1 
HIV exposure 1 2.0 2.2 0 1 
Asthma 1 2.0 2.2 1 0 
Diabetes 1 2.0 2.2 1 0 
Kidney problems 1 2.0 2.2 0 1 
Lung problems 1 2.0 2.2 0 1 
Septic wounds 1 2.0 2.2 0 1 
STD 1 2.0 2.2 1 0 
Down syndrome 1 2.0 2.2 1 0 
Tuberous sclerosis 1 2.0 2.2 0 1 
Blood clot deficiency 1 2.0 2.2 0 1 
Unknown 7 13.7 - 5 2 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 11 – 20 YEARS 
CLINICAL HISTORY CONTINUED 
Medicinal substance use All Males Females 
 n % with missing data (n=51) % of available data (n=43) n n 
None 27 52.9 62.8 10 17 
Pharmaceutical products 16 31.4 37.2 7 9 
Traditional medicine 0 0.0 0.0 0 0 
Unknown 8 15.7 - 5 3 
Chronic medication All Males Females 
 n % with missing data (n=51) % of available data (n=43) n n 
No 32 62.7 74.4 11 21 
Yes 11 21.6 25.6 6 5 
Unknown 8 15.7 - 5 3 
Medicinal substances All Males Females 
 n % with missing data (n=51) % of available data (n=29) n n 
Contraceptive 4 7.8 13.8 0 4 
Prescription medication 3 5.9 10.3 3 0 
Paracetamol 2 3.9 6.9 1 1 
Acetaminophen 1 2.0 3.4 1 0 
Antibiotics 1 2.0 3.4 1 0 
Carbamazepine 1 2.0 3.4 0 1 
Ceftriaxone 1 2.0 3.4 1 0 
Clobazam 1 2.0 3.4 0 1 
Clonazepam 1 2.0 3.4 1 0 
Constipation medication 1 2.0 3.4 1 0 
Dexamethasone 1 2.0 3.4 1 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 11 – 20 YEARS 
CLINICAL HISTORY CONTINUED 
Medicinal substances continued All Males Females 
 n % with missing data (n=51) % of available data (n=29) n n 
Diazepam 1 2.0 3.4 0 1 
Lorazepam 1 2.0 3.4 1 0 
Mesalamine 1 2.0 3.4 0 1 
Metoclopramide 1 2.0 3.4 1 0 
Morphine 1 2.0 3.4 1 0 
Pantoprazole 1 2.0 3.4 0 1 
TB medication 1 2.0 3.4 0 1 
Theophylline 1 2.0 3.4 1 0 
Triamcinolone 1 2.0 3.4 1 0 
Valproic acid 1 2.0 3.4 1 0 
Vigabatrin 1 2.0 3.4 0 1 
Vitamin C 1 2.0 3.4 1 0 
Family history of illness All Males Females 
 n % with missing data (n=51) % of available data (n=39) n n 
None 23 45.1 59.0 11 12 
Asthma 5 9.8 12.8 3 2 
Previous sudden death 5 9.8 12.8 2 3 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 11 – 20 YEARS 
CLINICAL HISTORY CONTINUED 
Family history of illness 
continued 
All Males Females 
 n % with missing data (n=51) % of available data (n=39)  n 
Heart disease 4 7.8 10.3 2 2 
High blood pressure 3 5.9 7.7 1 2 
Cancer 1 2.0 2.6 0 1 
Diabetes 1 2.0 2.6 1 0 
Blood clot deficiency 1 2.0 2.6 0 1 
Unknown 12 23.5 - 5 7 
 
NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
SOCIAL HISTORY 
Types of housing All Males Females 
 n % with missing data (n=199) % of available data (n=106) n n 
Formal 54 27.1 50.9 38 16 
Informal 52 26.1 49.1 34 18 
Unknown 93 46.7 - 56 37 
Substances of abuse All Males Females 
 n % with missing data (n=199) % of available data (n=165) n n 
None 59 35.8 35.8 31 28 
Alcohol 72 43.6 43.6 49 23 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
SOCIAL HISTORY CONTINUED 
Substances of abuse continued All Males Females 
 n % with missing data (n=199) % of available data (n=165) n n 
Tobacco 50 30.3 30.3 33 17 
Illicit drugs 45 27.3 27.3 35 10 
Unknown 34 - - 22 12 
Specific substances All Males Females 
 n % with missing data (n=199) % of available data (n=208) n n 
Beer 52 26.1 25.0 38 14 
Cigarettes 42 21.1 20.2 27 15 
Cannabis 24 12.1 11.5 21 3 
Methamphetamine 22 11.1 10.6 17 5 
Brandy 19 9.5 9.1 15 4 
Methaqualone 15 7.5 7.2 14 1 
Wine 12 6.0 5.8 7 5 
Spirits 4 2.0 1.9 4 0 
Heroin 4 2.0 1.9 3 1 
Whoonga 3 1.5 1.4 2 1 
Hubbly 3 1.5 1.4 3 0 
Ciders 2 1.0 1.0 0 2 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
SOCIAL HISTORY CONTINUED 
Specific substances continued All Males Females 
 n % with missing data (n=199) % of available data (n=208) n n 
Whiskey 2 1.0 1.0 1 1 
Sniff 1 0.5 0.5 0 1 
Cat 1 0.5 0.5 1 0 
Cocaine 1 0.5 0.5 1 0 
Buttons 1 0.5 0.5 1 0 
Not specified 16 8.0 - 12 4 
Physical activity All Males Females 
 n % with missing data (n=199) % of available data (n=2) n n 
Yes 2 1.0 100.0 2 0 
Unknown 197 99.0 - 126 71 
CLINICAL HISTORY 
Symptoms prior to death All Males Females 
 n % with missing data (n=199) % of available data (n=156) n n 
None 5 2.5 3.2 4 1 
Breathlessness 55 27.6 35.3 31 24 
Vomiting 46 23.1 29.5 29 17 
Foaming at mouth 41 20.6 26.3 25 16 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
CLINICAL HISTORY CONTINUED 
Symptoms prior to death 
continued 
All Males Females 
 n % with missing data (n=199) % of available data (n=156) n n 
Chest pain 40 20.1 25.6 27 13 
Fitting 31 15.6 19.9 18 13 
Severe headaches 30 15.1 19.2 10 20 
Abdominal pain 28 14.1 17.9 17 11 
Vomiting blood 13 6.5 8.3 10 3 
Blood from mouth 12 6.0 7.7 7 5 
Fever 10 5.0 6.4 5 5 
Nose bleeds 10 5.0 6.4 6 4 
Diarrhoea 9 4.5 5.8 3 6 
Paralysis of limbs 9 4.5 5.8 4 5 
Coughing 7 3.5 4.5 2 5 
Coughing up blood 7 3.5 4.5 7 0 
Foaming at nose 6 3.0 3.8 4 2 
Urinated 5 2.5 3.2 1 4 
Abdominal distension 4 2.0 2.6 2 2 
Dizzy 4 2.0 2.6 3 1 
Swollen legs 3 1.5 1.9 1 2 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
CLINICAL HISTORY CONTINUED 
Symptoms prior to death 
continued 
All Males Females 
 n % with missing data (n=199) % of available data (n=156) n n 
Stiff neck 2 1.0 1.3 1 1 
Salivating 2 1.0 1.3 1 1 
Lethargy 2 1.0 1.3 2 0 
Heart burn 2 1.0 1.3 2 1 
Difficulty swallowing 1 0.5 0.6 0 1 
Nausea 1 0.5 0.6 1 0 
Arm blisters 1 0.5 0.6 1 0 
Mucus from nose 1 0.5 0.6 0 0 
Swollen neck/face 1 0.5 0.6 1 0 
Allergic reaction 1 0.5 0.6 0 0 
Back pain 1 0.5 0.6 1 0 
Not specified 1 0.5 - 1 0 
Unknown (not witnessed) 42 21.1 - 31 11 
Chronic illness/acute 
illness/infection during lifetime 
All Males Females 
 n % with missing data (n=199) % of available data (n=175) n n 
None 84 48.0 48.0 60 24 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
CLINICAL HISTORY CONTINUED 
Chronic illness/acute 
illness/infection during lifetime 
continued 
All Males Females 
 n % with missing data (n=199) % of available data (n=175) n n 
TB exposure 24 13.7 13.7 15 9 
Epilepsy 20 11.4 11.4 13 7 
HIV exposure 15 8.6 8.6 1 14 
Asthma 10 5.7 5.7 7 3 
High blood pressure 9 5.1 5.1 5 4 
Mental disease 8 4.6 4.6 6 2 
Obesity 6 3.4 3.4 2 4 
Heart problems 5 2.9 2.9 2 3 
Flu 5 2.9 2.9 2 3 
Allergies 5 2.9 2.9 4 1 
Disability 3 1.7 1.7 3 0 
Diabetes 2 1.1 1.1 1 1 
Kidney problems 2 1.1 1.1 0 2 
Cancer 2 1.1 1.1 1 1 
Malnutrition 2 1.1 1.1 1 1 
Lung problems 1 0.6 0.6 0 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
CLINICAL HISTORY CONTINUED 
Chronic illness/acute 
illness/infection during lifetime 
continued 
All Males Females 
 n % with missing data (n=199) % of available data (n=175) n n 
Septic wounds 1 0.6 0.6 1 0 
Ulcers 1 0.6 0.6 0 1 
Jaundice 1 0.6 0.6 0 1 
Abdominal pain 1 0.6 0.6 1 0 
Arthritis 1 0.6 0.6 0 1 
Malaria 1 0.6 0.6 0 1 
Fainting 1 0.6 0.6 0 1 
Chicken pox 1 0.6 0.6 0 1 
STD 1 0.6 0.6 1 0 
Low blood pressure 1 0.6 0.6 0 1 
Seizures 1 0.6 0.6 0 0 
Acute limb ischaemia 1 0.6 0.6 1 0 
Marfan syndrome 1 0.6 0.6 1 0 
Sleep apnia 1 0.6 0.6 1 0 
Norwegian scabies 1 0.6 0.6 0 1 
Liver failure 1 0.6 0.6 0 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
CLINICAL HISTORY CONTINUED 
Chronic illness/acute 
illness/infection during lifetime 
continued 
All Males Females 
 n % with missing data (n=199) % of available data (n=175) n n 
Gangrene 1 0.6 0.6 0 1 
Headaches 1 0.6 0.6 1 0 
Meningitis 1 0.6 0.6 1 0 
Mumps 1 0.6 0.6 0 1 
Unknown 24 13.7 - 18 6 
Medicinal substance use All Males Females 
 n % with missing data (n=199) % of available data (n=158) n n 
None 97 61.4 61.4 68 29 
Pharmaceutical products 61 38.6 38.6 31 30 
Traditional medicine 1 0.6 0.6 0 1 
Unknown 41 25.9 - 29 12 
Chronic medication All Males Females 
 n % with missing data (n=199) % of available data (n=168) n N 
No 122 72.6 72.6 80 42 
Yes 46 27.4 27.4 26 20 
Unknown 31 18.5 - 22 9 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
CLINICAL HISTORY CONTINUED 
Medicinal substances All Males Females 
  n % with missing data (n=199) % of available data (n=96) n n 
Contraceptive 9 4.5 9.4 0 9 
Paracetamol 9 4.5 9.4 6 3 
Prescription medication 9 4.5 9.4 7 2 
Epilepsy medication 8 4.0 8.3 6 2 
TB medication 8 4.0 8.3 4 4 
Asthma medication 5 2.5 5.2 2 3 
Antiretrovirals 4 2.0 4.2 0 4 
Pain medicine 3 1.5 3.1 1 2 
Tramadol 3 1.5 3.1 2 1 
Blood pressure medication 2 1.0 2.1 2 0 
Chlorpheniramine 2 1.0 2.1 1 1 
Psychiatric medication 2 1.0 2.1 1 1 
Risperidone 2 1.0 2.1 2 0 
Valproic acid 2 1.0 2.1 2 0 
Acamprosate calcium 1 0.5 1.0 1 0 
Acetaminophen 1 0.5 1.0 1 0 
Amoxicillin 1 0.5 1.0 1 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
CLINICAL HISTORY CONTINUED 
Medicinal substances continued All Males Females 
  n % with missing data (n=199) % of available data (n=96) n n 
Bisacodyl enema 1 0.5 1.0 0 1 
Brown powder 1 0.5 1.0 0 1 
Carbamazepine 1 0.5 1.0 1 0 
Ciprofloxacin 1 0.5 1.0 0 1 
Erythromycin 1 0.5 1.0 0 1 
Flu pill 1 0.5 1.0 1 0 
Fluoxetine 1 0.5 1.0 1 0 
Flupentixol decanoate 1 0.5 1.0 1 0 
Freshen 1 0.5 1.0 1 0 
Furosemide 1 0.5 1.0 0 1 
Ibuprofen 1 0.5 1.0 0 1 
Lithium carbonate 1 0.5 1.0 1 0 
Lorazepam 1 0.5 1.0 1 0 
Metoclopramide 1 0.5 1.0 1 0 
Orphenadrine 1 0.5 1.0 1 0 
Pantoprazole 1 0.5 1.0 0 1 
Phenytoin 1 0.5 1.0 0 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
CLINICAL HISTORY CONTINUED 
Medicinal substances continued All Males Females 
 n % with missing data (n=199) % of available data (n=96) n n 
Promethazine 1 0.5 1.0 1 0 
Rizatriptan 1 0.5 1.0 0 1 
Rufinamide 1 0.5 1.0 1 0 
Scopolamine 1 0.5 1.0 1 0 
Sulfamethoxazole 1 0.5 1.0 0 1 
Ulcer medication 1 0.5 1.0 0 1 
Warfarin 1 0.5 1.0 0 1 
Water medication 1 0.5 1.0 1 0 
Not specified 18 9.0 - 12 4 
Family history of illness All Males Females 
 n % with missing data (n=199) % of available data (n=145) n n 
Unknown 55 37.9 - 34 21 
None 90 62.1 62.1 59 31 
Asthma 20 13.8 13.8 12 8 
Heart disease 19 13.1 13.1 14 5 
Cancer 19 13.1 13.1 10 9 
Previous sudden death 12 6.0 8.3 8 4 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 21 – 30 YEARS 
CLINICAL HISTORY CONTINUED 
Family history of illness 
continued 
All Males Females 
 n % with missing data (n=199) % of available data (n=145) n n 
Diabetes 7 3.5 4.8 4 3 
High blood pressure 5 4.8 4.8 3 2 
Stroke 1 0.7 0.7 1 0 
TB 1 0.7 0.7 1 0 
Renal failure 1 0.7 0.7 1 0 
 
NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
SOCIAL HISTORY 
Types of housing All Males Females 
 n % with missing data (n=345) % of available data (n=183) n n 
Formal 88 25.5 48.1 58 30 
Informal 95 27.5 51.9 66 29 
Unknown 162 47.0 - 109 53 
Substances of abuse All Males Females 
 n % with missing data (n=345) % of available data (n=295) n n 
None 85 24.6 28.8 32 53 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
SOCIAL HISTORY 
Substances of abuse continued All Males Females 
 n % with missing data (n=345) % of available data (n=295)  n 
Alcohol 144 41.7 48.8 110 34 
Tobacco 124 35.9 42.0 98 26 
Illicit drugs 83 24.1 28.1 70 13 
Unknown 50 14.5 16.9 37 13 
Specific substances All Males Females 
 n % with missing data (n=345) % of available data (n=486) n n 
Cigarettes 118 34.2 24.3 94 24 
Beer 112 32.5 23.0 89 23 
Methamphetamine 49 14.2 10.1 39 10 
Cannabis 41 11.9 8.4 39 2 
Wine 37 10.7 7.6 23 14 
Brandy 37 10.7 7.6 32 5 
Methaqualone 36 10.4 7.4 31 5 
Spirits 15 4.3 3.1 10 5 
Heroin 15 4.3 3.1 13 2 
Papsak 7 2.0 1.4 6 1 
Whiskey 4 1.2 0.8 3 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
SOCIAL HISTORY 
Specific substances All Males Females 
 n % with missing data (n=345) % of available data (n=486) n n 
Ciders 4 1.2 0.8 0 4 
Whoonga 3 0.9 0.6 3 0 
Cocaine 2 0.6 0.4 1 1 
Traditional beer 1 0.3 0.2 1 0 
Sniff 1 0.3 0.2 0 1 
Buttons 1 0.3 0.2 1 0 
Glue 1 0.3 0.2 0 1 
E-cigarettes 1 0.3 0.2 1 0 
Speed 1 0.3 0.2 1 0 
Not specified 25 7.2 - 21 4 
Physical activity All Males Females 
 n % with missing data (n=345) % of available data (n=8) n n 
Yes 9 2.6 100.0 7 2 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY 
Symptoms prior to death All Males Females 
 n % with missing data (n=345) % of available data (n=269) n n 
None 13 3.8 4.8 8 5 
Breathlessness 96 27.8 35.7 59 37 
Chest pain 75 21.7 27.9 52 23 
Vomiting 67 19.4 24.9 33 34 
Foaming at mouth 49 14.2 18.2 27 22 
Abdominal pain 48 13.9 17.8 28 20 
Fitting 42 12.2 15.6 31 11 
Severe headaches 42 12.2 15.6 23 19 
Nose bleeds 20 5.8 7.4 17 3 
Diarrhoea 19 5.5 7.1 13 6 
Vomiting blood 19 5.5 7.1 14 5 
Coughing 18 5.2 6.7 13 5 
Fever 15 4.3 5.6 7 8 
Blood from mouth 14 4.1 5.2 12 2 
Paralysis of limbs 14 4.1 5.2 7 7 
Abdominal distension 12 3.5 4.5 7 5 
Urinated 6 1.7 2.2 5 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Symptoms prior to death 
continued 
All Males Females 
 n % with missing data (n=345) % of available data (n=269) n n 
Stiff neck 6 1.7 2.2 3 3 
Difficulty swallowing 6 1.7 2.2 3 3 
Coughing up blood 5 1.4 1.9 3 2 
Dizzy 5 1.4 1.9 4 1 
Nausea 5 1.4 1.9 3 2 
Arm blisters 5 1.4 1.9 1 4 
Salivating 4 1.2 1.5 3 1 
Swollen legs 4 1.2 1.5 2 2 
Leg pain 4 1.2 1.5 3 1 
Lethargy 4 1.2 1.5 1 3 
Heart burn 4 1.2 1.5 3 1 
Foaming at nose 3 0.9 1.1 1 2 
Mucus from nose 2 0.6 0.7 0 2 
Allergic reaction 1 0.3 0.4 1 0 
Vaginal discharge 1 0.3 0.4 0 1 
Bleeding heavily 1 0.3 0.4 0 1 
Anal bleeding 1 0.3 0.4 1 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Symptoms prior to death 
continued 
All Males Females 
 n % with missing data (n=345) % of available data (n=269) n n 
Fluid from ear 1 0.3 0.4 1 0 
Shoulder pain 1 0.3 0.4 1 0 
Not specified 2 0.6 - 2 0 
Unknown (not witnessed) 74 21.4 - 56 18 
Chronic illness/acute 
illness/infection during lifetime 
All Males Females 
 n % with missing data (n=345) % of available data (n=312) n n 
None 125 36.2 40.1 92 33 
TB exposure 54 15.7 17.3 36 18 
High blood pressure 35 10.1 11.2 19 16 
HIV exposure 32 9.3 10.3 12 20 
Asthma 23 6.7 7.4 15 8 
Mental disease 19 5.5 6.1 11 8 
Epilepsy 18 5.2 5.8 12 6 
Obesity 16 4.6 5.1 8 8 
Diabetes 14 4.1 4.5 8 6 
Heart problems 13 3.8 4.2 11 2 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Chronic illness/acute 
illness/infection during lifetime 
continued 
All Males Females 
 n % with missing data (n=345) % of available data (n=312) n n 
Flu 11 3.2 3.5 6 5 
Allergies 8 2.3 2.6 4 4 
Kidney problems 7 2.0 2.2 4 3 
Cancer 4 1.2 1.3 3 1 
Lung problems 3 0.9 1.0 2 1 
Pneumonia 3 0.9 1.0 3 0 
Septic wounds 2 0.6 0.6 2 0 
Sinus 2 0.6 0.6 2 0 
Ulcers 2 0.6 0.6 2 0 
Bronchitis 2 0.6 0.6 1 1 
Arthritis 2 0.6 0.6 0 2 
Hernia 2 0.6 0.6 1 1 
Anaemic 2 0.6 0.6 0 2 
Disability 1 0.3 0.3 0 1 
Jaundice 1 0.3 0.3 1 0 
Stomach bug 1 0.3 0.3 1 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Chronic illness/acute 
illness/infection during lifetime 
continued 
All Males Females 
 n % with missing data (n=345) % of available data (n=312) n n 
Abdominal pain 1 0.3 0.3 0 1 
Malaria 1 0.3 0.3 1 0 
Fainting 1 0.3 0.3 1 0 
Toothache 1 0.3 0.3 0 1 
Sore throat 1 0.3 0.3 0 1 
Low blood pressure 1 0.3 0.3 0 1 
High cholesterol 1 0.3 0.3 1 0 
Psoriasis 1 0.3 0.3 0 1 
Urinary problems 1 0.3 0.3 0 1 
Hidradenitis 1 0.3 0.3 0 1 
Gastroesophageal disease 1 0.3 0.3 0 1 
Appendicitis 1 0.3 0.3 0 1 
Ataxia with non-obstructive 
jaundice 
1 0.3 0.3 1 0 
Broken leg 1 0.3 0.3 1 0 
Stroke 1 0.3 0.3 1 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Chronic illness/acute 
illness/infection during lifetime 
continued 
All Males Females 
 n % with missing data (n=345) % of available data (n=312) n n 
Sore feet and legs 1 0.3 0.3 1 0 
Subcutaneous emphysema 1 0.3 0.3 1 0 
Unknown 33 9.6 - 27 6 
Medicinal substance use All Males Females 
 n % with missing data (n=345) % of available data (n=289) n n 
None 171 49.6 59.2 129 42 
Pharmaceutical products 115 33.3 39.8 60 55 
Traditional medicine 4 1.2 1.4 3 1 
Unknown 56 16.2 - 41 15 
Chronic medication All Males Females 
 n % with missing data (n=345) % of available data (n=306) n n 
No 212 61.4 69.3 150 62 
Yes 94 27.2 30.7 52 42 
Unknown 39 11.3 - 31 8 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Specific substances All Males Females 
 n % with missing data (n=345) % of available data (n=182) n n 
Prescription medication 19 5.5 10.4 11 8 
Antiretrovirals 14 4.1 7.7 4 10 
Paracetamol 13 3.8 7.1 5 8 
TB medication 11 3.2 6.0 8 3 
Contraceptive 10 2.9 5.5 0 10 
Asthma medication 7 2.0 3.8 4 3 
Blood pressure medication 7 2.0 3.8 4 3 
Epilepsy medication 7 2.0 3.8 6 1 
Acetylsalicylic acid 5 1.4 2.7 3 2 
Depression medication 5 1.4 2.7 3 2 
Amitriptyline hydrochloride 4 1.2 2.2 1 3 
Enalapril maleate 3 0.9 1.6 1 2 
Hydrochlorothiazide 3 0.9 1.6 0 3 
Tramadol 3 0.9 1.6 1 2 
Amlodipine 2 0.6 1.1 1 1 
Antacid 2 0.6 1.1 1 1 
Carvedilol 2 0.6 1.1 2 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Specific substances continued All Males Females 
 n % with missing data (n=345) % of available data (n=182) n n 
Flu medication 2 0.6 1.1 1 1 
Ibuprofen 2 0.6 1.1 1 1 
Insulin 2 0.6 1.1 1 1 
Magnesium 2 0.6 1.1 0 2 
Muti 2 0.6 1.1 1 1 
Repaglinide 2 0.6 1.1 1 1 
Simvastatin 2 0.6 1.1 2 0 
Aluminium-magnesium hydroxide 1 0.3 0.5 1 0 
Amoxicillin 1 0.3 0.5 0 1 
Analgesics 1 0.3 0.5 0 1 
Antibiotics 1 0.3 0.5 0 1 
Antirejection medication 1 0.3 0.5 1 0 
Atenolol 1 0.3 0.5 1 0 
Atorvastatin calcium 1 0.3 0.5 1 0 
Bipolar medication 1 0.3 0.5 0 1 
Camphor 1 0.3 0.5 0 1 
Cancer medication 1 0.3 0.5 1 0 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Specific substances continued All Males Females 
 n % with missing data (n=345) % of available data (n=182) n n 
Carbamazepine 1 0.3 0.5 0 1 
Cimetidine 1 0.3 0.5 1 0 
Ciprofloxacin 1 0.3 0.5 0 1 
Clopidogrel 1 0.3 0.5 1 0 
Codeine 1 0.3 0.5 0 1 
Corenza C 1 0.3 0.5 1 0 
Dextromethorphan 1 0.3 0.5 0 1 
Diabetes medication 1 0.3 0.5 0 1 
Diclofenac sodium 1 0.3 0.5 1 0 
Ferritin 1 0.3 0.5 0 1 
Fluoxetine 1 0.3 0.5 0 1 
Furosemide 1 0.3 0.5 1 0 
Green fluid 1 0.3 0.5 0 1 
Green tablets 1 0.3 0.5 1 0 
Hydrocortisone 1 0.3 0.5 0 1 
Isosorbide dinitrate 1 0.3 0.5 1 0 
Kidney medication 1 0.3 0.5 0 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Specific substances continued All Males Females 
 n % with missing data (n=345) % of available data (n=182) n n 
Lorazepam 1 0.3 0.5 0 1 
Meperidine 1 0.3 0.5 0 1 
Morphine 1 0.3 0.5 1 0 
Ondansetron hydrochloride 1 0.3 0.5 1 0 
Orphenadrine 1 0.3 0.5 1 0 
Orange powder 1 0.3 0.5 1 0 
Pain medication 1 0.3 0.5 1 0 
Phenobarbital 1 0.3 0.5 0 1 
Phentermine 1 0.3 0.5 1 0 
Pneumonia medication 1 0.3 0.5 1 0 
Prednisone 1 0.3 0.5 1 0 
Propranolol 1 0.3 0.5 0 1 
Pyridoxine 1 0.3 0.5 1 0 
Rehydrat 1 0.3 0.5 1 0 
Salt solution 1 0.3 0.5 1 0 
Sandoz 1 0.3 0.5 1 0 
Sleeping medication 1 0.3 0.5 0 1 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Specific substances continued All Males Females 
 n % with missing data (n=345) % of available data (n=182) n n 
Sodium bicarbonate 1 0.3 0.5 1 0 
Sulfamethoxazole-trimethoprim 1 0.3 0.5 1 0 
Triamcinolone 1 0.3 0.5 1 0 
Vitamin C 1 0.3 0.5 0 1 
Vulform 1 0.3 0.5 0 1 
Water medication 1 0.3 0.5 1 0 
Zolpidem 1 0.3 0.5 0 1 
Not specified 7 2.0 - 5 2 
Family history of illness All Males Females 
 n % with missing data (n=345) % of available data (n=272) n n 
None 155 44.9 57.0 104 51 
Asthma 51 14.8 18.8 34 17 
Heart disease 39 11.3 14.3 29 10 
Cancer 27 7.8 9.9 17 10 
Previous sudden death 20 5.8 7.4 16 4 
Diabetes 14 4.1 5.1 10 4 
High blood pressure 11 3.2 4.0 6 5 
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NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES ONLY (n=661) 
AGE CATEGORY 31 – 40 YEARS 
CLINICAL HISTORY CONTINUED 
Family history of illness continued All Males Females 
 n % with missing data (n=345) % of available data (n=272) n n 
Stroke 1 0.3 0.4 0 1 
Epilepsy 1 0.3 0.4 1 0 
Arthritis 1 0.3 0.4 0 1 
Low blood pressure 1 0.3 0.4 1 0 
Unknown 73 21.2 - 49 24 
 
NON-SPECIFIC NATURAL, UNDETERMINED AND UNDER INVESTIGATION CASES (n=176) 
Biological sample availability n % of available data (n=176) 
Yes 144 81.8 
No 32 18.2 
Specific sample n % of available data (n=144) 
Blood only 46 31.9 
Tissue only 86 59.7 
Blood and tissue 12 8.3 
 
UNDETERMINED CASES ONLY (n=23) 
Was the body identified? n % of available data (n=23) 
No 7 30.4 
Yes 16 69.6 
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Gastro-intestinal sepsis and skin infection
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